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This section

provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.

IMMUNOLOGY AND CANCER
In the past decade various studies in pa
tients with cancer have greatly advanced our
knowledge of basic immunology. Now there
is some suggestion that this knowledge may
contribute to the treatment of such patients.
In this issue of the Journal (page 12) Proc
tor, Lewis and Mansell give an overview of
present and potential modalities of immuno
therapy.
The live antituberculosis vaccine, bacille
Calmette Guerin (BCG), which has been
widely studied in animals, has, since the
mid-1960s, shown suggestive immunotherapeutic potential in man; presumably it acts
as a nonspecific stimulator of cellular im
munity or macrophage activity. Canada is
in the forefront of randomized clinical trials
of this agent in bronchogenic carcinoma
and malignant melanoma, and these trials
should establish whether this agent has a
place in cancer treatment. Using retro
spective control groups, Morton and Gutterman in the United States, as well as some
Canadian groups, have carried out trials that
strongly suggest that BCG therapy can pro
long remission in cases of advanced malig
nant melanoma. There is, however, no doubt
that extensive surgical extirpation of the
cancer is vitally important before immuno
therapy can have any effect. And, to estab
lish the usefulness of immunotherapy, ran
domized trials are necessary because retro
spective control studies may be invalidated
by advances in surgical and chemothera
peutic management or changes in the nature
of the disease.
In cases of acute myeloid leukemia there
seems little doubt that nonspecific immune
stimulation can prolong remission. Both live
BCG and its methanol extractable residue
(MER) greatly increase the duration of re
mission and survival, but the role of specific

leukemic cell vaccines is still not clear. M a
lignant cells, usually irradiated and treated
in various ways in an attempt to enhance
immunogenicity, have appeared to improve
survival in bronchogenic carcinoma as well
as leukemia, but they may only be acting
as nonspecific stimulants to immunity. Tu
mour-specific immunity in man is very dif
ficult to measure by the present techniques.
Variables such as the BCG strain, dosage,
viability of organisms, and route of admin
istration make it difficult to compare one
clinical trial with another.
Even if immunologic manipulation cannot
achieve tumour rejection there is little doubt
that the state of the immune system in a
patient with cancer is an important progno
stic indicator. Immunocompetence may be
measured by skin tests against recall anti
gens such as purified protein derivative
(PPD) or mumps, new antigens such as dinitrochlorobenzene (DNCB) or in-vitro stimu
lation of lymphocytes by nonspecific mito
gens such as phytohemagglutinin. Even a
simple test such as the total lymphocyte
count has some prognostic value. Several
investigators have shown that a patient’s
prognosis can be predicted by reference to
immunologic parameters even when these
are studied independently from traditional
factors such as age, sex, histologic features
of the tumour and extent of disease.
Debate continues about the simplest and
best parameters to study, but some day
these will be used to stratify patients going
into trials of new forms of surgical treat
ment or adjuvant chemotherapy.
Although immunotherapy must remain
experimental, the place of immunodiagnosis
is continually gaining importance. Radio
immunoassays of hormones such as calci
tonin and parathormone not only can con-
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firm the diagnosis of a tumour but also,
when coupled with selective venous cannulation, can help the surgeon localize the
lesion. Carcinoembryonic antigen may aid
in the diagnosis of gastrointestinal cancer,
and it is already being used to detect early
recurrence in prospective trials of adjuvant
chemotherapy for carcinoma of the gastroin
testinal tract, lung and breast. The diagnosis
and chemotherapeutic management of gesta
tional neoplasms (female choriocarcinomas)
and testicular tumours depends greatly on
the radioimmunoassay of the serum hor
mones LH and HCG. And in some parts of
the world (Russia and tropical Africa), the
early detection of alpha-fetoprotein in a

Vol. 19

patient’s serum can lead to the discovery of
a primary hepatoma while it is still surgical
ly curable.
In November 1975 the New York Acad
emy of Sciences held a meeting on the im
munobiology and immunotherapy of can
cer. The published proceedings of this meet
ing will review much of the basic knowledge
in this area, but there is obviously still much
to be learned. The immunologist has gained
a prominent place in cancer investigation
and is now establishing a role in the man
agement of the cancer patient.
P. B. M c C u l l o c h , MD, FRCP[C]
McMaster University,

Hamilton, Ont.

SELF-ASSESSMENT
SESAP II QUESTION
317. Which of the following statements concerning sutures made from polyglycolic acid
(Dexon) is/are correct?
(1)
(2)
(3)
(4)

Absorption is complete within 60 days
They have less tensile strength than cotton and silk sutures
They are absorbed by hydrolysis rather than proteolysis
They are weakened if infection develops

For this question one or more of the answers given above is correct. Your answer should
be:
A if only 1, 2 and 3 are correct,
B if only 1 and 3 are correct,
C if only 2 and 4 are correct,
D if only 4 is correct,
E if all are correct.
For the critique of Ttem 317 see page 80 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Sylla
bus: Surgical Education and Self-assessment Program No. 2.)
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Hepalean
...most frequently ordered anticoagulant in Canada
Hepalean

Heparin Sodium U.S.P.
for injection... used for an ever increasing
number of indications1— thromboembolism,
lung embolism, coronary heart disease, renal
disease and hemodialysis, obstetrics, and as
a concomitant drug in many areas, “ . . . an
extremely effective drug for the manage
ment of thrombosis. Properly given, it rapidly
and reliably arrests thrombosis and prevents
embolization, especially on the venous side
of the circulation” 2
In an international trial of heparin for lowdose prophylaxis involving 4121 patients3
“ sixteen deaths in the control and two in the

►

Contraindications: Conditions with bleeding tendencies, hemophilia
and severe clotting disorders; shock, hypersensitivity to heparin,
severe liver damage.
Precautions: Large doses should be delayed four hours post-operatively. Use with caution during pregnancy and postpartum. Use with
caution in patients with allergy. Long term use should be monitored
for the possible development of osteoporosis.
Adverse Effects: Hypersensitivity reactions.
Hepalean Dosage and Administration: Parenteral. The following
amounts, indicated by prothrombin time determinations. Usual adult
dose; Intravenous, 10,000 U.S.P. Heparin Units initially, then 5,000A

Harris Laboratories
Brantford, Canada.

heparin group were ascribed to acute mas
si ve p u l m o n a r y e mb o l i s m (P<0.0024).”
“Taking all pulmonary emboli together, the
finding of a four fold reduction (22 vs. five)
was also significant (P< 0.005).”
"Thus the final link in establishing the valid
ity of low-dose heparin prophylaxis for post
operative venous throm boem bolism for
those at high risk after general abdomino
thoracic surgical procedures has been pro
vided.” “ (5000 units at eight or 12 hours daily
given subcutaneously and referred to as lowdose heparin)”4

10,000 units 4-6 times a day; Infusion, 20,000 to 40,000 units per litre
at a rate of 15-30 units per minute. Subcutaneous, 10,000 to 20,000
units initially, then 8,000 to 10,000 units 3 times a day. Usual pediatric
dose, intravenous infusion, 50 units per kg of body weight initially,
followed by 100 units per kg, or 3333 units per square metre of body
surface 6 times a day.
Reference: 1. H eparin: Recent Abstracts of the Biomedical Litera
ture, Excerpta Medica, 1975.
2. Edward Genton M .D ., G uidelines for Heparin Therapy,
Annals of Internal M edicine 80:77-82,1974.
3. Kakkar V .V . Corrigan TP, Fossard DP; Prevention of
fatal postoperative pulmonary embolism by low doses of
heparin: an international m ulticentre trial. Lancet 2:45-51,
1975.
4. Sherry S., “ Low Dose Heparin Prophylaxis for Post
operative VenousThrom boem bolism ’’ NewEnglandJournal of M ed icine 293 No. 6:300-302,1975.
For full prescribing inform ation, see package insert.
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IMMUNOTHERAPY FOR CANCER: AN OVERVIEW*
J. W. PROCTOR, MB, BS, PhD, M. G. LEWIS, MD, FRCPath(Eng) and
P. W. MANSELL, MA, MB, BCh, FRCS(Eng)t
Summary: Immunotherapy of cancer is of in
terest to oncologists because it is specifically
directed to cancer cells, sparing normal cells.
While it is ineffective in most patients, espe
cially those with widespread metastatic disease,
it occasionally produces good results. Each of
the available methods has inherent problems
and, recently, attempts have been made to over
come some of these. There is a strong case
for small-scale experimental trials in highly se
lected groups of patients who are intensively
investigated for their immunologic status in
relation to their tumour. Despite the lack of
success in general, immunotherapy still appears
to have a future as an adjunct to existing ther
apy in order to control as much as to cure
residual tumour.
Resume: L'immunotherapie du cancer interesse
les oncologistes, parce que cette methode com
bat directement les cellules cancereuses, tout
en epargnant les cellules normales. Bien qu'elle
soit inefficace chez la plupart des cancereux,
surtout chez ceux porteurs de metastases etendues, elle donne parfois de bons resultats.
Toutes les methodes anticancereuses ont leurs
inconvenients propres et, dernierement, on a
tente de surmonter certains de ces inconve
nients. II y a la un champ interessant pour des
essais experimentaux sur une echelie reduite,
chez des groupes de malades qui sont actuellement etudies quant a leur statut immunologique
en regard de leur tumeur. Malgre I'absence
generate de succes, l'immunotherapie semble
encore assure d’un certain avenir, ne fut-ce que
comme un adjuvant des traitements existants,
ou elle pourrait enrayer et meme guerir des
tumeurs residuelles.

fections. These first attempts in humans
were based on the observations that animals
exposed to a tumour rejected a subsequent
challenge, probably through a reaction
against the then unrecognized group of histoincompatibility antigens rather than
against tumour-specific antigens, since the
animals used were outbred.
Although occasional cases of objective
regression occurred in these early series,
Woglom1 in 1929 concluded his survey of
tumour immunology by stating, “Nothing
may be hoped for at present in respect to a
successful therapy in this direction.”
A n t it u m o u r I m m u n it y

Gross- in 1943, Lewis and Aptekman3
in 1951 and other, later workers demon
strated the existence of “tumour-specific
antigens” in inbred animal systems. It was
then found that human patients mounted
immunologically specific reactions against
a variety of cancers, which led to the re
cent upsurge of interest in immunotherapy.
Both cellular and humoral factors and
combinations of the two probably consti
tute effector mechanisms against tumours
(Fig. 1). Most of these mechanisms have
been worked out in vitro and their use has
been reviewed by Berkelhammer.4 By fol
lowing the course of a patient sequentially
and quantitating the various indices, several

T h e concept of stimulating and augmenting

antitumour immune responses in the treat
ment of human cancer arose in the last 2
decades of the 19th century and followed
the recognition of immunity to bacterial in*From McGill University cancer research unit,
McGill University, Montreal, Que.
tDepartment of oncology, Royal Victoria Hos
pital, Montreal.
Reprint requests to: Dr. J. W. Proctor, McGill
University cancer research unit, 3655 Drummond
St., Montreal, PQ H3G 1Y6.

Fig. L - Presumed effector mechanisms in anti
tumour immunity, c = cellular mechanism, h =
humoral mechanism.
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Fie 2 -Representation ot events occurring ai stages m lumuui f
—
conceptual, but is based on data obtained in studies of tumours in animals and in man.

workers have been able to make satisfactory
correlations with the stage and even the his
tologic type of tumour.5'8
The series of events taking place during
the various stages in tumour progression is
represented in Fig. 2. Although largely con
ceptual the schema is based on data ob
tained in studies of a variety of tumours in
animals and in man. The course of events
can be summarized as follows:
1. During growth of the primary tumour
it is likely that there is a lag period before
immunity is initiated by the presentation of
tumour antigen to the local draining lymph
nodes; however, what governs the length
of the lag period is not known.
2. Chronic persistent antigenic stimula
tion, as is the case in tumour development,
then leads to a “paralysis” of the draining
lymph nodes and a decrease in the number
of sensitized cells released from these
lymph nodes.0
3. At the same time, the increasing con
centration of antigen in the blood may
neutralize antitumour antibody10 and an
apparent state of nonreactivity develops be

fore metastases become clinically detect
able,5 though whether this actually leads to
metastatic spread or the metastatic spread
itself results in a state of nonreactivity is
not yet established.
4. Removal of the primary tumour in
animals leads to “unblocking” of the para
lyzed lymph nodes0 and, even in the pres
ence of metastases, to a decrease in blood
antigen concentrations associated with a
rise in humoral antibody titres10 and re
storation of detectable immunity in the
blood (J. W. Proctor, unpublished observa
tions).
5. The further growth of metastases ul
timately leads to a second disappearance
of detectable immunity before the meta
stases are detected clinically.11
P lace and T iming of I m m u n o th er a py

Even though immunotherapy has no place
in the treatment of resectable primary tu
mours, it may be useful in the treatment of
residual tumours after surgical treatment,
chemotherapy or radiotherapy, or in com
bination therapy regimens. Immunotherapy
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is most efficacious shortly after operation,
when the mass of residual tumour is small
est and when there is a natural increase in
the patient’s immune activity. This does not
exclude immunotherapy later, as lymph
nodes draining areas away from those af
fected by secondary tumour are not neces
sarily maximally stimulated at this time
and, theoretically, could be boosted with
a suitably placed injection of antigen. Nor
is there any reason to suppose that there is
any limit to the amount of tumour that
may be destroyed by a persistent effective
immune response, though this in itself may
be difficult to achieve. Further, when chem
otherapy must be discontinued because of
side effects and when the tumour mass has
been sufficiently diminished there is un
doubtedly a place for immunotherapy, when
the immunocompetence of the patient is
being reestablished.
Why do T umours G row
an I mmune R esponse?

D espite

target itself presents a major problem: there
is a theoretical possibility that, for instance,
immunizing a patient with his own tumour
cells may augment either the cytotoxic or
the blocking mechanisms.
I mmunocompetence

of the

A

\

P atient

This discussion has considered specific
immunologic effects and has not taken into
account the further problem confronting the
immunotherapist: in the absence of immu
nosuppressive measures, such as chemother
apy and radiotherapy, there may be a pro
found decrease in immunocompetence to un
related as well as previously unencountered
antigens. This has been a controversial is
sue and, though there is no doubt that with
terminal malignant disease, as with advanced
tuberculosis, there is an overall debilitation
including that affecting the immune system,
there is increasing evidence that in a num
ber of cancers generalized immunoincompetence precedes terminal illness17- 13 and
can even occur quite early in the disease.
Of interest, therefore, is the finding that,
in the presence of anergy to skin sensitizing
agents and common nontumour antigens,
immunization with a tumour or with a non
specific adjuvant can provoke a shortlived
but readily detectable specific reaction . 19
Thus, when one considers immunologic
status it is necessary to distinguish between
general immunocompetence with regard to
nontumour antigens and specific compe
tence against the tumour.
I mmunotherapy in
and M an

V

4

£> r

When one is considering the problem
confronting the would-be immunotherapist,
it is worth remembering that, although tu
mour-specific immunologic reactions are
frequently detected in patients with cancer,
the cancer almost always progresses relent
lessly and often eventually kills the patient.
Thus the clinician must hope to succeed
where nature herself has failed.
The reasons for the failure of defence
mechanisms that in vitro often appear to
function adequately are probably numerous
and extremely complex; but there is no
doubt that, if they could be unravelled suf
ficiently, a more rational approach to aug
menting immune responses would follow.
Among the possible reasons for this fail
ure, the existence of immunologically me
diated blocking phenomena” 1- that prevent
immunologic killing of tumour cells ranks
as one of the most likely explanations.
These phenomena include antibody, 13-15
antigensN and antigen/antibody complex
es3- 10 and are postulated to act variously
on the afferent, the central, or the efferent
limbs of an immune response, or on all of
these. The objective of immunotherapy
should be to boost the immunologically cy
totoxic mechanisms without increasing the
so-called blocking mechanisms, and this

Vol. 19

4

A nimals

Although immunoprophylaxis (immuniza
tion preceding an injection of tumour cells)
has been easy to achieve in animal models,
immunotherapy (immunization designed to
cause regression of existing tumours) has
been rather more difficult, and has been
only possible at all while tumours are still
lelatively small.-’0- 21 The immunogenicity
(the capacity for a tumour to provoke an
immune response) has proved important in
immunotherapy in animal models;22- 23 in
general, the more highly immunogenic, the
greater the success.
The detailed historical aspects of immu
notherapy in humans, well reviewed by Cur
rie, 24 will not be discussed in this paper.

4
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Specific immunization
Category of
immunotherapy

Components
of therapy

Nonspecific
immunization

Potential
problems

Facilitation
Neutralization on
repeated injection
Graft-versus-host
disease
None known

Active

Syngeneic / allogeneic
attenuated tumour cells

Cellular
(adoptive)

1. Allogeneic/xenogeneic
lymphocytes
2. Extracts from com
ponents of 1 , e. g.,
transfer factor, im
mune RNA
1. Allogeneic/xenogeneic/ Anaphylaxis, serum
syngeneic antibody
sickness
2. Ctmrponents of 1 linked Blocking substances
to radiotherapeutic and
chemotherapeutic
agents

Serum
(passive)

llld lL d U )

p iu u iv

t

the available methods will be summarized
and a brief account of the rather recent
practical steps being taken to circumvent
such problems will be presented.
In general, although occasional patients
have benefited from most of the forms of
therapy the majority of such patients have
manifested no evidence of objective regres
sion.
The available methods for immunother
apy, many of which were being attempted
before 1920, are summarized in Table I.
Active Therapy
Specific immunization.—The use of live
tumour cells is associated with the potential
risk of active tumour growth and, with few
exceptions, most workers have used either
killed or attenuated vaccines. Most com
monly irradiated tumour cells are used, but
recently it now appears that treatment of
cells with mitomycin C, glutaraldehyde, iodoacetate, or neuraminidase produces more
satisfactory preparations. Neuraminidase
has been shown in several systems to in
crease the immunogenicity of tumour cells,
probably by means of digestion of sialic
acid residues in the glycocalyx of the cells
rendering antigenic determinants more
available.25
A potential problem of this form ot
therapy is raised by the finding in animals
that spontaneous blood-borne metastatic
spread may be facilitated or suppressed26'28
after autoimmunization, depending on the

Adjuvants
(bacterial, chemical)
Allogeneic lymphocytes

Allogeneic/xenogeneic
properdin, interferon,
humoral recognition
factor, reagin
^

used for immunization. Apart from Risley s
series29 we do not know of any reported
case of clinical deterioration following auto
vaccination and, in our own experience of
treating more than 75 patients, we have not
even suspected that this might have occur
red. One must remember, however, that
most patients so treated had advanced dis
ease and by definition a poor prognosis. It
is unlikely that facilitation of tumour spread
or growth would have been noticed in light
of the fact that further growth and spread
usually occurs relatively rapidly in such pa
tients, irrespective of treatment.
Nonspecific immunization.— A number
of adjuvants, including bacterial vaccines,
some chemical compounds, and fractions of
them, produce a nonspecific stimulation of
the reticuloendothelial system and aug
ment humoral and cellular responses to un
related antigens. Of these agents, BCG (bacille Calmette Guerin) is best known,30' 31
though much data are available for other
agents such as Corynebacterium parvum,32
C. granulosum , 33 polyinosinic-polycytidylic
acid,34 zymosan and its derivative glucan,,>J
levamisole30 and Triton W .R."1 in animal
models. No one agent has been compared
definitively to another, so that at present
little may be said of their relative merits.
Most of them have been shown to be ef
fective in some animal systems and inef
fective in others.
In general, these agents act nonspecifically by stimulating the reticuloendothelial sys-

L U U I U U I
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---- ---------

-
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tem and by augmenting specific antitumour
reactions. The latter supposedly might re
sult from macrophage-mediated mechan
isms, including better processing of tumour
antigens for lymphocyte stimulation, more
active clearance of abrogating antigen-an
tibody complexes from the blood, or the
provision of more specifically armed or nonspecifically activated cytotoxic antitumour
macrophages.
There are indications that, as in the case
of specific active immunization, the dose is
important,88' 89 as is the time point89 41 in
the disease at which these agents are admin
istered, and also the route of administra
tion.49- 41 The activity of BCG has been
shown to be greater after intravenous or intraperitoneal administration to animals;40' 41
and whether or not this should hold true
for agents such as glucan in man may
determine which of these many agents will
be preferred by clinicians. Serious side ef
fects have been reported after intradermal
and, particularly, intratumoural injection of
BCG,4- and obviously the incidence of sys
temic infection is likely to increase follow
ing intravenous or intraperitoneal injection.
Of interest, therefore, are the attempts to
use C. parvum intravenously reported by
Israel and Edelstein,43 and separately used
by Woodruff and colleagues (Ghaffar, per
sonal communication, 1974), apparently
with only very transient (less than 24 hours)
side effects including fever and malaise.
A further theoretical drawback to the
use of the bacterial agents is that they are
all highly immunogenic. Their repeated use
could produce an increasingly rapid and ef
fective antiadjuvant immune response,24
which would neutralize the adjuvant before
it stimulates the reticuloendothelial system
to any great extent. Thus, it may be neces
sary to have a large selection of such agents,
which could be used sequentially.
Adoptive Therapy
Specific immunization. — Lymphocytes
are widely regarded as constituting a major
effector mechanism in the rejection of skin
grafts, and thus of solid tumours in the
form of the delayed hypersensitivity reac
tion. This type of immunity can be trans
ferred adoptively by injection of sensitized
lymphocytes in normal individuals.44- 45

Vol. 19

The strength of any reactions mounted
against a tumour after cross-immunization
and cross-transfer of lymphocytes is more
likely to be related to the degree of histoincompatibility than to tumour antigens. If
reactions are to be successful, it is likely that
a generalized graft-versus-host (GVH) re
action would have to be mounted and the
advantages of suffering from this form of
disease rather than cancer are dubious, to
say the least. A failure to mount a GVH
reaction, on the other hand, would probably
result from rejection of the foreign lympho
cytes, which would immediately nullify any
beneficial effects they might have produced
had they survived.
Two further forms of adoptive immuno
therapy warrant close attention, both in
volving cell-free extracts of lymphocytes.
One can readily appreciate that the disad
vantages of using whole allogeneic or xeno
geneic lymphocytes, which can cause un
wanted side effects of GVH reactions or
which will be destroyed by an intact im
mune response in the recipient, are poten
tially overcome by using such extracts. The
first of these other forms of therapy is use
of transfer factor, a dialyzable extract of
peripheral blood lymphocytes that can
specifically transfer delayed hypersensitivity
reactions (cellular immunity) in man and
some animals.4«' 47 The second is the use
of RNA extracts from sensitized lympho
cytes demonstrated to convert nonimmune
lymphocytes to specific immunologic activ
ity, both in vitro48 and in vivo.49
This work has led to therapeutic attempts
in a small number of cancer patients47’ 49
and, though insufficient time has elapsed to
permit one to make only the most tentative
conclusions, there is no doubt that these
approaches are promising. Recently, quanti
ties of transfer factor have been produced
from selected lymphoblastoid cell lines in
tissue culture following stimulation with
small amounts of transfer factor (Viza, per
sonal communication, 1975). This enrich
ment procedure will facilitate production of
transfer factor from sera obtained from pa
tients during early stages of the disease for
treatment should they become immunoincompetent later on. It obviates the need for
cross-immunization of patients or the use of
animal products and can be achieved with-
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out greatly depleting the patients of a neces
sary component of their immune defence
against the tumour.
Nonspecific immunization.— As with the
use of sensitized lymphocytes, there is
little evidence that this form of therapy has
been successful on its own. The problems
inherent in specific adoptive therapy apply
to nonspecific therapy, and it is doubtful
whether this form of therapy has any po
tential advantages over specific therapy.
Passive Therapy
Specific immunization.— One of the ear
liest forms of therapy, the use of im
mune serum has not proved particularly suc
cessful. Recently, in animals50"52 and in
man— in two cases of melanoma53' 54—
antiserum linked to chemotherapeutic or radiotherapeutic agents was associated with
tumour regression. Results of work in ani
mals is increasingly promising, though all
reports concern xenogeneic or allogeneic an
tisera. The problem of administering serum
from one species to another is that natural
antibodies to the immunoglobulin of the
species used for obtaining the antiserum
may be present in the recipient, and it can
be expected that the antiserum may be de
stroyed relatively rapidly, particularly with
repeated injection. With repeated therapy
there is a potential risk of serum sickness
or anaphylaxis,53 and the possibility of the
putatively bad effects of blocking antibody
has to be considered.
The use of autogenous antisera obtained
at an early stage of the disease linked to
radiotherapeutic or chemotherapeutic agents
is practical and would obviate the potential
problems associated with the use of xeno
geneic antisera.
Nonspecific immunization.— A number
of humoral substances, including reagin and
properdin are present in so-called normal
sera, some of which might act nonspecifically to augment the immune response. A
factor present in normal serum humoral
recognition factor (HRF) has been observed
to disappear prior to the leukemic phase in
an animal leukemia grown as a solid tumour
(Di Luzio, personal communication, 1975).
It crosses species barriers and, experimental
ly, appears to be important in allowing full
function of the reticuloendothelial system.
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The early results from assaying cancer pa
tients indicate that serum concentrations of
HRF are low,55 and there may be a case
in the future for treatment with fresh pre
parations of the substance.
Nonspecific passive therapy so far has
not been used to any great extent.
Therapy to Remove Blocking Substances
It is theoretically possible to remove
blocking substances by passing blood through
either antigen- or antibody-containing col
umns or plates as a form of hemodialysis;
the technologic base for this is essentially
available already.56 However, until it can
be established whether antigen itself, antigen/antibody complexes, “enhancing” anti
body or antiantibody57' 58 are present in
each patient and actively blocking immun
ity, this approach must remain a hope.
C o n c lu sio n s

The status of immunotherapy remains ill
defined and most patients with cancer do
not benefit from any of the many approach
es available. However, throughout the 80year history of immunotherapy the occa
sional objective remission has been the rule
in most series and such remission, con
sidered with the unarguable success en
countered in many animal systems, pro
vides evidence that these forms of treatment
can be successful.
What in fact can immunotherapy offer
in relation to the more conventional modes
of therapy? Surgical procedures have and
probably always will hold the prime posi
tion in the treatment of accessible solid
tumours. Chemotherapy and radiotherapy
alone or in combination have produced re
markable effects in some forms of cancer,
particularly those of the lymphoreticular
system, and have proved most useful as an
adjunct to surgical procedures in the treat
ment of metastatic disease. Chemotherapy
and radiotherapy make use of semiquantitative differences between normal and neo
plastic cells and thus tend to destroy sensi
tive and often vital normal tissue. The great
potential value of immunotherapy is that
it distinguishes between normal and neo
plastic tissue, specifically destroying tu
mour cells and sparing the normal cells.
The immune system is complex. The re-
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cent rapid increase in our knowledge of its
role in neoplasia, still far from complete,
has served to confuse as much as clarify
the issues. The value of multiple in-vitro
tests has not been firmly established, as
correlations with the stage of disease have
been made only infrequently. Without a full
understanding of the process it is unlikely
that it will be possible to repair adequately
what is, after all, a defective antitumour
mechanism. If, as studies of animal models
suggest, the number of irradiated tumour
cells or the dose of an adjuvant such as
BCG, is critical in clinical practice, then
for a single patient who has, for example, a
primary melanoma with a prognosis rang
ing from only 6 months to as long as 15
years, the chances of guessing correctly cer
tainly are slim.
The best approach for clinicians at pres
ent is to select from a number of different
regimens one that is based on results ob
tained in other patients who have had dis
ease, the features of which closely resemble
those in a particular patient, but this is
feasible in only a few types of cancer.
A clinical success without any monitor
ing of immunologic indices merely keeps us
at the same point as that of the clinicians
of 50 years ago and is unlikely to benefit
future patients. There is no reason to sup
pose that exactly the same course of ther
apy will benefit the next or most of the
succeeding patients who will be more or
less immunocompetent with greater or
smaller amounts of residual tumour. The
treatment of diabetes with insulin produced
both bad and good results until the meas
urement of blood sugar and electrolyte con
centrations became routinely available.
Thus, there is an urgent need to establish
which of the many in-vitro tests are of value
in assessing the status of the host-tumour
relationship, establishing prognoses and per
mitting the early detection of recurrence.
This could be greatly aided by the investiga
tion of patients undergoing immunotherapy,
as changes in an immunologic index asso
ciated with an objective remission are like
ly to be highly significant.
However, these investigations are timeconsuming and costly and require highly
trained personnel. They are not practical
in the large numbers of cases required for
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relatively large-scale clinical trials.
These issues seem necessarily to militate
against large-scale trials in most types of
cancer, and probably only those trials in
volving homogeneous classes of patients
with a poor prognosis receiving conventional
therapy are justified or indeed will yield
results that can be readily analyzed in a
reasonable period.
Therefore there seems to be a case for
rather short-term, small-scale, perhaps even
uncontrolled trials of therapy in a few pa
tients. There would be a poor chance of a
statistically significant result, but detailed
sequential monitoring of many immunologic
indices could be carried out. Regimens could
be altered relatively frequently and could
be based on observations of measured in
creases or decreases in the levels of immu
nologic indices providing a more rational
approach to what is, after all, a highly am
bitious endeavour.
Results from such small trials could be
applied in setting up more formal, larger
trials in the future. The emphasis in the
past has been on providing a cure and,
while this is still the ultimate goal, it is less
realistic than that of controlling residual tu
mour— one does not cure chronic heart
failure, hypertension, or diabetes, but the
control of these diseases is undeniably suc
cessful. The numerous reports of patients
with cancer who, often without any treat
ment apart from surgical removal of the
primary tumour, live free of symptoms for
years before succumbing to their disease
support the concept that control is a prac
tical possibility.
Immunotherapy is unlikely ever to pro
vide the sole answer to any cancer. It may
well have a place as an adjunct to other
forms of therapy; perhaps the keynote at
present should be cautious optimism.
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an emerging problem.
“Bacteroides species are often over
looked as a cause of serious infec
tion both by clinicians and micro
biologists. They are most commonly
associated with intra-abdominal
and pelvic sepsis following gastro
intestinal surgery.”

“Our experience with this series of seriously
ill patients provides clinical confirmation to
complement recent in vitro evidence that '
clindamycin is the antibiotic of choice for
use in bacteroides infections. Not only was;*
the response in 17 of the 18 patients favour
able, but in several it was dramatic.”

Tracy, 0 .,e t al.(29 Jan.’72).
Brit. med.J.,p. 280.

Haldane, E. V. and van Rooyen,C.E. (1972).
C.M.A.J.,p. 1177.
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CAS INUSITE DE KYSTE HYDATIQUE OPERE*
L. DONTIGNY, MD, FRCS[C], C. MERCIER, MD, A. PAGE, MD, R. LEVY, MD,
R. COSSETTE, MD, FRCS[C], C. PELLETIER, MD, FRCS[C] et
A. VERDANT, MD, FRCS[C]
Resume: Presentation d'un cas inusite d’echinococcose originant de la rate avec extension
trans-diaphragmatique au poumon, chez une patiente grecque ayant vecu sur une ferme d'elevage de moutons. Ouelques points essentiels
sont releves sur I'epidemiologie, les elements
diagnostiques et le traitement de cette maiadie.
Summary: A hydatid cyst of the spleen devel
oped in a Greek-Canadian woman who had lived
on a sheep farm. The cyst extended through the
diaphragm to the left lower lobe. Splenectomy
and left lower lobectomy and excision of con
tiguous diaphragm were performed. Histopatho
logic examination confirmed the presence of
hydatid cysts in both spleen and lung. Postoper
ative course was uneventful. In Canada hydatid
disease is rare and its occurrence sporadic. It
is commoner among Canadian Indians and im
migrants than native Canadians. Treatment is
surgical; en bloc excision of tissue eliminates
the possibility of anaphylaxis or dissemination
of scolices.

L ’echinococcose humaine parmi la popu
lation autochtone du Canada demeure une
rarete, mais l’inimigration en constitue une
nouvelle source croissante. C’est le cas de
notre patiente d’origine grecque qui presen
te une atteinte primitive de la rate avec
extension pulmonaire trans-phrenique.
H istoire de cas

Une patiente de 60 ans, nee en Grece et
immigree au Canada depuis plusieurs annees,
consultait une premiere fois a l’Hopital du
Sacre-Coeur de Montreal pour troubles gynecologiques, et une radiographie pulmonaire de
routine revelait une image suspecte a la base
gauche (fig. 1). L’investigation bronchoscopique et bronchographique permettait d’exclure
une atteinte pulmonaire. Au pneumoperitoine,
la rate apparaissait calcifiee et fixee au dome
*Travail du service de chirurgie cardio-vasculaire
et thoracique, departement de Chirurgie, Hopital
du Sacre-Coeur de Montreal, Montreal, Que.
Les demandes de tires-a-part doivent etre addres
sees a: L. Dontigny, md, Service de chirurgie
cardio-vasculaire et thoracique, Departement de
chirurgie, Hopital du Sacre-Coeur de Montreal,
5400, ouest blvd Gouin, Montreal, PQ H4J 1C5.
diaphragmatique. Le diagnostic d’echinococco-

se de la rate n’a pas ete precise, mais devant
cette lesion asymptomatique et d’aspect non
evolutif, aucun traitement n’a ete suggere.
Dix-huit mois plus tard, la patiente est admise de nouveau en vue d’une hysterectomie
pour metrorragies et l’image initiale notee sur
la radiographie du poumon a nettement progresse (fig. 2). Le pneumoperitoine est repete
et laisse apercevoir la meme lesion de la rate
qui est calcifiee et adherente au diaphragme
mais qui semble maintenant deborder au-dela
de celui-ci (fig. 3). Par ailleurs, la bronchographie nous permet de deceler la presence de niveaux hydroaeriques a la peripherie du lobe
inferieur gauche, un processus actif a ce
niveau (fig. 4). Cette zone correspond a l’image deja mise en evidence sur les cliches sim
ples et semble egalement fixee au diaphragme
sous-jacent. Le diagnostic de maiadie hydatique a depart splenique est maintenant soupgonne. La patiente demeure asymptomatique,
avec une formule sanguine normale sauf une
eosinophylie controlee a 9% . Devant cette le
sion evolutive, malgre un tableau clinique
tout-a-fait silencieux, une thoracotomie posterolaterale gauche a ete pratiquee. II s’agissait effectivement d’une lesion “en sablier” originant
de la rate, avec envahissement pulmonaire a
travers le diaphragme. La lesion a ete resequee
en bloc par voie thoracique, comprenant la
splenectomie, l’exerese d’une collerette dia
phragmatique en continuite avec la lobectomie
inferieure gauche. L’examen histopathologique
confirmait le diagnostic par la presence de
plusieurs kystes hydatiques dans la rate et le
poumon. Devolution post-operatoire fut sans
incident.
D iscussion

La maiadie hydatique causee par l’echinocoque granulosus se retrouve de fagon
endemique particulierement dans les contrees d’elevage de moutons, avec en fete
PAmerique du Sud, l’Australie, la NouvelleZelande et les pays du pourtour Mediteranneen. Elle y presente un cycle dit domestique, alors qu’au Canada le meme parasite
est vehicule par un cycle sylvestre1 et la
maiadie est relativement rare et de nature
sporadique. Une etude canadienne extensive
sur le sujet revelait que la tres grande ma-

i
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Fig. 1.—Image peripherique arrondie a la base
gauche.

Fig. 3.—La rate presente des calcifications; elle
est fixee au diaphragme de meme qu’au poumon
adjacent.

Vol. 19

Fig. 2 .-L ’image a nettement progresse.

Fig. 4.—Bronchographie montra une image hydroaerique en Peripherie du lobe inferieur gauche.
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jorite des 162 cas rapportes etaient des
Indiens, vivant dans l’Ouest du pays.2’ 3
Aucun cas dans cette serie n’etait rapporte
au Quebec et ce n’est qu’en 1956 que Begin,
Guy et Raymond,4 publiaient deux cas, operes a l’Hopital du Sacre-Coeur de Montreal;
tous deux venaient de l’Abitibi. Par contre,
de plus en plus de cas sont retrouves parmi
notre population immigrants, sur 35 cas
rapportes a Toronto en 1963, 29 venaient
de pays infestes par le parasite; un bon nombre etaient Italiens.5
Le kyste hydatique primitif et isole de
la rate est egalement rare; lors d’une etude
autopsique, Deve6 donnait une incidence
de 2.3% . Par ailleurs, l’atteinte pulmonaire
que l’on rencontre, isolee ou non, est habituellement primitive et l’extension directe
de la maladie a travers le diaphragme, particulierement a point de depart splenique,
est une evolution tres atypique en soi.
Comme elements diagnostiques, nous re
tenons principalement les sources epidemiologiques bien caracteristiques. A la radiographie, les calcifications de la rate a la lumiere d’une reactivation du processus, suggerent une lesion de nature inflammatoire;
le tableau clinique est nettement en faveur
d’une lesion benigne et les images pulmonaires demeurent compatibles avec une at-
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teinte kystique. L’eosinophylie a 9% opte
pour une parasitose. Les divers tests biologiques suggeres, incluant l’intradermoreaction de Casoni, n’ont pas ete faits.
Le traitement de l’echinococcose consti
tute demeure chirurgical; certains cas particuliers pourront parfois beneficier d’une
approche non-chirurgical.7 L ’exerese en bloc
est le traitement de choix de fagon a eviter
la contamination per-operatoire, eliminant
ainsi la possibilite d’anaphylaxie ou d’ensemencement de scolex.
R eferences
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PRIMARY CARCINOMA OF THE GALLBLADDER:
STUDY OF 108 CASES*
P. F. RICHARD, M D, FR C Sf and J. C A N TIN , M D, FRCS[C], FACSlj;

Summary: From 1948 through 1970, 108 cases
of primary carcinoma of the gallbladder were
recorded out of a total of 17 698 cases of
cancer exclusive of skin cancer (incidence,
0.6%). This review indicated that the following
are the chief features of this condition: Primary
gallbladder carcinoma is mainly a disease of
women older than 60 years; abdominal pain oc
curs in most patients and jaundice in more than
half, and weight loss is also common; labora
tory and radiographic features are nonspecific;
the diagnosis is made or strongly suspected in
only one-quarter and, moreover, in many patients
the disease may not be discovered until patho
logic examination is conducted postoperatively.
Resection was possible in 41 of the 93 patients
who underwent operation but treatment was
conservative because it was palliative in 20,
and in 20 of the other 21 who underwent chole
cystectomy the disease was not recognized at
operation. Overall, the 5-year survival rate was
6.4%; for those who underwent curative resec
tion it was 33%; and for patients without visible
metastases at operation the mean survival was
3 years. Improvement in survival will come from
more frequent recognition of the cancer at
operation so that an operation more adequate
than cholecystectomy may be performed; that
is, cholecystectomy, wedge resection of liver
and resection of regional lymph nodes.
Resume: Sur un total de 17 698 cas de cancer
de tous genres, sauf les cancers cutanes, nous
avons releve, de 1948 a 1970, 108 cas de carcinome primaire de la vesicule biliaire (fre
quence, 0.6%). La presente revue a permis de
preciser les caracteres principaux de cette pathologie: le carcinome primaire de la vesicule
biliaire frappe, avant tout, des femmes de plus
de 60 ans; une douleur abdominale est presente
chez la majorite des malades et I'ictere chez
plus de la moitie; I'amaigrissement est chose
courante; les examens de laboratoire et les
radiographies n'offrent rien de specifique. Le
*From the department o f surgery, Hotel-Dieu
Hospital and University of Montreal, Montreal,
Que.
fFormerly resident in surgery, Hotel-Dieu Hos
pital, Montreal.
{Surgeon, Hotel-Dieu Hospital, and associate pro
fessor, faculty o f medicine, University o f Mont
real.
Reprint requests to: Dr. Jacques Cantin, Depart
ment of surgery, Hotel-Dieu Hospital, 3840 St.
Urbain, Montreal, PQ H2W 1T8.

diagnostic n'est pose ou fortement soupconne
que chez moins d'un quart des malades, a tel
point que, dans nombre de cas, la maladie n'est
decouverte qu'a I'occasion d'un examen pathologique postoperatoire. Chez 41 des 93 malades
operes, on a pratique la resection mais ce traitement a ete conservateur, n’ayant constitue qu'un
palliatif chez 20 malades. Chez 20 des 21 autres
patients qui ont subi une cholecystectomie, le
carcinome n'a meme pas ete decele lors de
I'operation. Dans I'ensemble, le taux de survie
de 5 ans a ete de 6.4%, tandis que chez les
malades oil la resection avait un caractere curatif, la survie a ete de 3 3 % . Quant aux malades
dont les metastases eventuelles n'etaient pas
visibles lors de I'operation, la survie moyenne
n'a pas depasse 3 ans. La prolongation de la
survie ne deviendra une realite que par une
identification plus frequente du cancer lors de
I’intervention, celle-ci pouvant alors etre pratiquee d’une faqon differente et plus appropriee
que la simple cholecystectomie, comportant,
outre celle-ci, la resection cuneiforme du foie
et la resection des ganglions lymphatiques
regionaux.

described in 1771 by de Stoll, pri
mary carcinoma of the gallbladder still
carries a poor prognosis.1 The silent pro
gression of this cancer, without signs or
symptoms, has made early diagnosis for
tuitous. Usually, it is diagnosed during ex
ploratory laparotomy, and resection is not
attempted— either because the disease is
extensive or because most surgeons are
discouraged by the poor prognosis of the
disease and do not wish to treat it aggres
sively. However, knowledge of its natural
history is necessary in view of the frequency
of gallbladder operations and of the pro
gressively increasing age of the population.
We have therefore studied our experience
with primary carcinoma of the gallbladder.

F ir s t

I n c id e n c e

From 1948 to 1970 inclusive, 108 cases
of primary malignant neoplasms of the gall
bladder were recorded in the tumour registry
of Hotel-Dieu Hospital, Montreal. These
cases were drawn from a total of 17 698
cases of cancer (exclusive of skin), of which
517 originated in the hepatobiliary-pancrea-
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TABLE I.—Age

Sex D istribution

Sex
--------------------------Male
Female

Age
(yr)
40
50
60
70
80

and

- 49 .........................
- 59 .........................
- 6 9 .........................
- 79 .........................
- 8 9 .........................
Total...........

4
0
11
6
1
22 (20%)

2
11
40
26
7
86 (80%)

tic tract. The incidence of primary carci
noma of the gallbladder was, therefore,
0.6% of all cancers (exclusive of skin) and
20.8% of cancers arising in the hepatobili
ary-pancreatic area. During the last 5 years
of this study, 3237 cholecystectomies were
performed and 26 cancers of the gallbladder
diagnosed; carcinoma was thus encountered
in a little less than 1 % (0.8%) of operations
on the gallbladder.
C linical D etails, R esults of
Investigations and D iagnosis
Clinical Details
Age and sex distribution of patients re
vealed that carcinoma of the gallbladder was
predominantly a disease of women (80%)
of an older age group (84% over 60 years
of age) (Table I).
The symptoms and signs and their in
cidence are summarized in Table II. Ab
dominal pain was the most frequent com
plaint; in 42 patients it was the only symp
tom and in 46 it was accompanied by jaun
dice. Pain was of four types (Table II).
TABLE II.—S ymptoms

and

Symptom or sign
Abdominal pain.................................
Biliary colic....................................
Chronic cholecystitis.....................
Acute cholecystitis....................
Vague upper abdominal pain..

S igns
No. (and %)
of patients
(n = 108)
91 (84)
40(37)
29(27)
11 (10)
11 (10)

Jaundice..............................................

57 (52)

With abdominal pain...............
Without abdominal pain.........

46 (42)
11 (10)

General symptoms
Nausea........................................
Weight loss (> 4.5 kg)...........
Anorexia......................................
Vomiting.....................................
Melena..............................................
Asymptomatic.........................................

70
68
59
42

(65)
(63)
(55)
(39)
8(7)
2(2)
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Jaundice was noted in more than half of the
patients. Weight loss (> 4.5 kg) was noted
by 68 patients and was a predominant
finding.
Physical examination revealed hepato
megaly alone in 28 patients and hepato
megaly with an associated right upper quad
rant mass in 26. Ascites was noted in 20,
a mass in the right upper quadrant in 14.
Laboratory Findings
Anemia (Hb < 10 g/di) was noted in
32 patients and leukocytosis (> 10 x 10!'/Z)
in 41. Features of extrahepatic obstruction
were usually noted in jaundiced patients.
Radiographic Findings
Cholangiographic (oral or intravenous)
findings were abnormal in 64 patients: in
24, stones were seen and in 40, a nonopacified gallbladder was visualized. A barium
meal was given to 72 patients: in 17 it
showed compression and narrowing at the
level of the antroduodenal area. Barium
enema examination was performed in seven
patients, in one of whom compression of
the hepatic flexure was visualized. Selective
celiac angiography was performed once; it
showed the typical “champagne-glass” de
formity (wide separation of the branches of
the cystic artery with an associated tumour
staining).
Diagnosis
Diagnosis was made or strongly suspected
before operation in 20 patients and at opera
tion or autopsy in 68. The diagnosis was
made postoperatively by the pathologist in
20 patients; with these patients, the surgeon
had been unaware during the operation of
the presence of cancer.
T reatment
An operation was performed in only 93
of the 108 patients (Table III). Resection
TABLE III.—T reatment
Operative
status and
treatment
Operability
Resectability
Palliative
Curative
No treatment

No. of patients
(and % of
total)
(n = 108)
93 (86)
41 (38)
20 (18.5)
21 (19.5)
15 (14)

% of patients
with
operable
condition

_
44
21.5
22.5
—
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TABLE IV.—T ype

of

TABLE VI.—P rincipal S ites

Operations

Operative status and type
oj operation
Resectable..................................
Cholecystectomy................
Cholecystectomy,
choledochotomy.............
Cholecystectomy + biliary
diversion.........................
Nonresectable............................
Biopsy alone.......................
Biopsy
cholecystostomy
Biopsy -f biliary diversion
Biopsy + gastro
enterostomy ....................

No. of patients
41
25
14

2

52

41

of

M etastasis

No. (and %)
of patients

Site
Regional nodes.............................
Liver.............................................
Contiguous only...................
Contiguous and distant.......
Distant only.........................
Lesser omentum..........................
Greater omentum........................
Gastroduodenal area...................

85
(79)
. 82
(76)
29
(27)
53
(49)
0
(0)
43
(40)
24
(22)
17 (16)

6

3

was possible in 41, with a view to cure in
21 and palliation in 20. The types of opera
tions are enumerated in Table IV. Because
in the case of 20 of the 21 patients who
had undergone curative resections the sur
geon did not learn until after the operation
that he had resected a carcinoma of the gall
bladder, the treatment in this group was
conservative: no liver resections were done.
P athologic F indings

Histologic Features and Associated
Lesions
Most tumours were adenocarcinomas with
a few squamous cell carcinomas and adenoacanthomas (Table V). The site of origin
could be ascertained in only a few cases,
and was evenly distributed between the
fundus, body and neck. Stones were found
in 90 patients (83% ) and were absent in 1,
though in this patient a cholecystoduodenal
fistula was present; for 17 patients there
was no mention of the presence or absence
of stones. Six patients had a second pri
mary cancer: the uterus, kidney, rectum,
breast, colon and ovary were affected.

and superior pancreatic nodes) were in
volved in 85 patients (79% ). The liver was
the next most frequent site of metastases,
in 82 (76% ). Distant spread alone to the
liver did not occur in this series.
Survival

Of the 108 patients 7 (6.4%) were alive
5 years after diagnosis (Fig. 1). The 5-year
survival rate for curative resections was
33% (7 of 21) (Fig. 2). The 1-year and 3year survivals, after laparotomy only and
after palliative resection, were identical: 5
and 2% , though the survivals at 3 and 6
survival

(%)

Fig. 1.—Primary

MONTHS
carcinoma

of

gallbladder.

Spread
Metastatic spread chiefly involved the he
patobiliary region (Table VI). The regional
nodes (i.e., cystic duct node, common duct
TABLE V.—C lassification of C ancer by H isto
logic

D iagnosis

Histologic diagnosis
Adenocarcinoma..........................
Epidermoid carcinoma................
Adenoacanthoma.........................

No. (and %)
of patients
(:n = 108)
96 (89)
7
(6.5)
5 (4.5)

Survival for 108 patients related to operative man
agement.
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months were slightly higher after palliative
resection, which probably reflects the extent
of the disease more than the type of opera
tion. Evidence that the mean postoperative
survival time is influenced by the extent of
disease found at laparotomy is supported by
the observation that it is 7 months when
nodes only are involved, but 4 months in
patients with liver metastases also. The
mean survival time, without gross visible
metastases at operation, was 3 years.
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were naturally reluctant to agree imme
diately to a second operation. Immediate
opening of all specimens by surgeon and
pathologist, and frozen-section examination
of any suspicious area, would eliminate un
expected pathologic reports4 and permit at
the same operation a more adequate resec
tion.12 The seven 5-year survivors were
among the 20 patients who underwent blind
resection by simple cholecystecomy without
the surgeon’s knowledge of the presence of
cancer; a more adequate cancer operation
D iscussion
in such patients might increase the survival
Gallbladder carcinoma is predominantly rate.
In patients in whom the gallbladder was
a disease of older women, found in approxi
mately 1% of all gallbladder operations.-’ 19 opened and carcinoma was discovered,
In our experience, it represents 0.6% of stones were found in all except one. This
association, noted by others619 in 60 to
all cancers (exclusive of skin cancer).
The signs and symptoms are unspecific 100% of patients, raises the problem of
and simulate those of benign gallbladder the carcinogenicity of gallstones. Prophylac
disease.6- 16' 18- 20 Consequently, when ac tic removal of all stone-containing gallblad
companied by a history of weight loss, parti ders on this indication alone, however, ap
cularly in an older person, these should pears difficult to support. Since 1000 such
alert the physician to the possibility of can cholecystectomies would yield 10 cancers,
cer. In the present series the diagnosis was and assuming an increased cure rate of
never made preoperatively in patients in 50% , the patients thus “saved” would be
whom curative resection was possible; con offset by a surgical mortality of 0.5% ,
versely, when preoperative diagnosis was which is minimal in an unselected group of
made or suspected, resection, even pallia patients.7'9 We think a better reason to ad
vocate cholecystectomy, apart from the re
tive, was rarely possible.
There are no specific routine laboratory lief of symptoms, is the avoidance of much
or radiologic features. Barium meal not in more frequent complications such as acute
frequently shows modifications in the antro- cholecystitis, choledocholithiasis and pan
duodenal area;13' 19' 21- 22 however, these creatitis.1- 13' 2:{
Our experience confirms the work of
can be found in benign acute inflammatory
gallbladder disease. A tortuous and irregular Fahim10 on metastatic routes of spread of
cystic artery, tumour staining and enlarge gallbladder carcinoma. Lymphatic spread to
ment of the area supplied by the artery the cystic duct node and along the common
giving the champagne-glass appearance is to duct nodes to the retropancreatic nodes ap
some degree specific of carcinoma of the pears to happen first, together with direct
gallbladder;21 but angiography cannot be invasion of the liver at the gallbladder
advanced as a routine method of investiga fossa. Distant liver metastasis denotes pres
tion, and its usefulness in early cases is ence of a long-standing cancer; this did not
occur in the present series without spread
probably minimal.
In our patients, except for one, operations by continuity. Fahim has reported a case of
that were thought to result in complete re a cancer lying on the hepatic side of the
section were accomplished before the sur gallbladder with a positive paracholedochal
geon was aware that carcinoma of the gall node without liver involvement at autop
bladder was present. In other words, ap sy.11 Booher and Pack3 and Wolma and
parently complete resection was accom Lynch24 have also reported two similar
plished by routine cholecystectomy, and this cases. That direct involvement of the liver
is certainly, from an oncologic point of also happens early is evident from a report
view, a very limited cancer opera by Brasfield5 who, after performing a rou
tion.r>- 14- 17- 19 Both surgeon and patient tine cholecystectomy, did a right hepatic
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lobectomy and found microscopic foci of
carcinoma in the gallbladder fossa, with
negative nodes. Knowledge of these routes
of spread is of prime importance in per
formance of resection of gallbladder cancer
that is more adequate than is afforded by a
simple cholecystectomy. In this series, 21
cholecystectomies were curative in intent;
that is, no evident disease was left, yet 14
patients died from cancer.
It is with this last group of patients that
the greatest improvements are possible. An
adequate operation in localized carcinoma
of the gallbladder should include removal
of known lymphatic routes of spread com
bined with at least a wedge resection of the
liver at the level of the gallbladder fossa.
We believe such an operation is not beyond
the tolerance of the older patients, in whom
we unhesitatingly perform abdominoperineal
resection of the rectum or radical gastrec
tomy. In other patients with evident cancer
in the gallbladder fossa, extensive hepatic
resection can be performed by an exper
ienced surgical team, at least in the younger
patients, though, in this latter group, the
possibility of increasing survival is probably
less than in other patients. Gastroentero
stomy may be considered in patients with
locally advanced disease and minimal liver
involvement.
Survival for the whole group was low,
though a 5-year survival rate of 33% was
obtained after “curative” resection.
C onclusion

Our experience with 108 primary gall
bladder carcinomas shows that it represents
less than 1% of all cancers (0.6%), and
that 20% of cancers arise in the hepato
biliary-pancreatic area. It is primarily a
disease of older women. In early cases, there
were no specific signs or symptoms, other
than those of benign gallbladder disease.
Gallbladder carcinoma spreads first to
regional nodes along the cystic and common
ducts, and to the liver at the gallbladder
fossa. Later spread is chiefly to the liver,
lesser and greater omentum and gastro
duodenal area.

For all patients the 5-year survival rate
was 6.4% , though in 21 patients in whom
resection was thought to be curative, the
5-year survival rate was 33% . All these

31

resections except one were done without
the surgeon’s knowledge of the presence of
cancer. Hopes for improving survival rates
lie in recognizing, at the time of operation,
that one is dealing with a primary gallblad
der carcinoma, so that an adequate cancer
operation is performed; that is, wedge re
section of the liver at the level of the gall
bladder fossa combined with resection of
regional lymph nodes.
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GLIMPSES OF SURGICAL HISTORY: G FOR GASTRIC SURGERY,
GASTROSTOMY, BEAUMONT AND ST. MARTIN
D. A. E. SHEPHARD

The first gastric operations were necessi
tated by the exigencies of trauma, and
elective GASTRIC SURGERY is of rela
tively recent origin. The first planned
GASTROSTOMY, for example, was per
formed in 1602, by Matthis of Prague, and
the second in 1635, by Swabe, an itinerant
surgeon, who had passed a knife down the
throat of this patient to induce vomiting
which caused the patient to swallow the
knife instead. But the most celebrated gas
trostomy, truly of traumatic origin, dates to
1822: the surgeon was William Beaumont
and the patient was Alexis St. Martin.
The Beaumont-St. Martin story does not
require description here, but some of its
lesser known aspects do bear repetition in
view of the theme of this alphabetic look at
the history of surgery: how persons other
than surgeons have influenced the develop
ment of surgical art. One such certainly was
St. Martin, who, because he allowed Beau
mont to study the actions and reactions of
his stomach, appreciably advanced the un
derstanding of surgical physiology.
Beaumont, remembered by Osier as “the
pioneer physiologist of America”, was an
accomplished surgeon besides, as his care of
St. Martin proved. But two points must be
made: St. Martin’s stomach wound was
important to Beaumont because it repre
sented the meeting of the man and his
opportunity, and Beaumont was extraordi
narily diligent in pursuing four series of
studies of gastric digestion despite the diffi
culties posed by his peripatetic military
career, St. Martin’s occasional, but natural,
desire to return to his native Canada from
various parts of the United States (wherever
—

Beaumont happened to be), the lack of re
search facilities, and the financial costs
involved. Even so, Beaumont was remark
ably successful in persuading both St.
Martin to stay with him as his research sub
ject and the US War Department to employ
St. Martin so he could be at his side during
his researches. Thus Beaumont was enabled
to conduct 238 experiments on St. Martin
over 11 years and to write his 1833 master
piece, “Experiments and Observations on
the Gastric luice and the Physiology of
Digestion”.
St. Martin was, not surprisingly, very
different from Beaumont, who was “a hum
ble inquirer after truth a simple experi
menter”. Beaumont treated him carefully
for 2 years but St. Martin would not accede
to Beaumont’s request to suture the lips of
the gastrostomy wound together and so
he unwittingly gave Beaumont the idea and
opportunity for his great work. But St.
Martin, a simple voyageur, periodically
eluded Beaumont by returning to Canada.
He knew Beaumont had made both of them
famous and that he could demand money
for his services and other scientists were
interested in him too but he remained
unreliable and truculent, perhaps unsurpris
ingly. As St. Martin himself wrote to Beau
mont after disappointing him,
“This’s just a snatch of Monsieur’s ways,
Thus go’s he on in tricks and lies,
And thinks to get well paid for it.”
But patients are not machines, and sur
geons must at times recall the debt that
surgery owes to them, one of whom was
Alexis St. Martin.
—

—

—

—
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DELAYED PRIMARY CLOSURE IN COLON OPERATIONS*
M. E. PAUL, MD, W. J. WALL, M D, FRCS[C] and J. H. D U F F , MD, FRCS[C]
Summary: Secondary closure of incisions by
tape is a simple, safe procedure. In a retro
spective series of 179 contaminated surgical
wounds (incisions for colon operations) delayed
wound closure resulted in a lower incidence of
wound infection (5 .8 % ) than did primary closure
of similar wounds (11.8% ). Although wounds left
open do become infected, the acute swelling
and systemic signs typical of an infection in a
closed wound never develop. Delayed closure
facilitated wound healing in hospital: only 3.8%
of patients thus treated left hospital with open
wounds, but 9.5% of patients whose wounds
were closed primarily left hospital with wounds
that were partially or completely open.
Resume: Une fermeture secondaire au moyen
d'un ruban adhesif est une methode simple et
sans danger. Apres avoir passe en revue une
serie de 179 plaies operatoires contaminees (in
cisions pour interventions sur le colon), la fer
meture retardee de la plaie a permis de reduire
la frequence de I'infection de la plaie (5 .8 % ) si
on compare ces resultats a ceux que donne la
fermeture primaire (1 1 .8 % ). S ’il est vrai que le
fait de laisser les plaies ouvertes ouvre la voie
a I'infection, il est tout aussi evident que la
tumefaction aigue et les signes generaux qui
sont typiques de I’infection d'une plaie suturee
ne se manifestent jamais. La fermeture retardee
a facilite la cicatrisation de la plaie durant le
sejour a I'hopital: un petit nombre des operes
de la sorte (3 .8 % ) ont quitte I’hopital avec des
plaies ouvertes, tandis que 9.5% des operes
ayant eu une fermeture primaire ont quitte I’hopital avec des plaies qui etaient partiellement
ou completement ouvertes.

infections cause appreciable mor
bidity and economic loss. They develop in
approximately 7.4% of the 18 million peo
ple having operations yearly in the United
States, with resultant cost of approximately
9.4 million dollars, or $7000.00 per infec
tion. 1 Many of these wound infections follow
colon operations that must be considered
contaminated. To decrease the incidence of
wound infections both the use of antibiotics
W ound

*From the departments of surgery, University
Hospital and Victoria Hospital, and the Univer
sity of Western Ontario, London, Ont.
Reprint requests to: Dr. J. H. D uff, Department
of surgery, University Hospital, 339 Windermere
Rd., London, ON N 6A 5A5.

and the technique of delayed closure have
been suggested.
John Hunter2 in 1794 was among the
first to describe the advantages of delayed
wound closure. Military surgeons have long
been convinced of the value of delayed
closure for contaminated wounds; for exam
ple, the NATO handbook, summarizing ex
perience gained in the two world wars and
in the Korean war, states that, after thorough
debridement of injured tissues, “the second
step is delayed primary wound closure, pre
ferably three to seven days after injury, the
indication for closure being the healthy ap
pearance of the wound”.3 Before the use
of tape,* delayed wound closure usually
required a general anesthetic, as sutures
were used after the wound edges were debrided and freshened, and for this reason
neither surgeon nor patient liked the pro
cedure. In contrast, the use of tape permits
secondary closure of wounds to be done
with ease on the ward; and, cosmetically,
wounds closed secondarily by tape are at
least as good as those closed primarily by
suture.
The aim of this study was to compare
primary closure by suture with delayed
closure by tape of contaminated wounds
with regard to incidence of infection and
wound status at the time of discharge from
hospital.
M ethods

A retrospective study was conducted of
the records of all patients who underwent
colon operations between November 1972
and July 1974. For all colon operations that
are classed as contaminated, we collected
data relative to the condition requiring co
lonic surgery, the type of bowel preparation,
the incidence of wound infections, the
status of the wound at the time of discharge
from hospital and the severity of systemic
manifestations. The criterion for the diag
nosis of wound infection was the presence
of pus.
*Steri-Strips,
USA.

3M

Company,

Minneapolis,

MN,
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TABLE I.—T ypes

of

Operations *

Anterior resection..............................................
Right hemicolectomy........................................
Closure of colostomy........................................
Segmental resection..........................................
Total colectomy.................................................
Abdominoperineal resection.............................
Other...................................................................
Total............................................................

TABLE II.—P athologic D iagnoses
60
34
33
23
17
10
2
179

*Wounds referred to in this study were the addominal incisions.

For wounds managed by delayed closure,
the protocol was the following: At operation
the fascia is closed and the skin and sub
cutaneous tissue are held open with rayon
and sterile gauze. The open wound is re
dressed daily. When it is judged clinically
suitable for closure—usually 3 to 5 days
after operation— the wound is closed with
tape on the ward. The dressing is removed
and the skin surrounding the wound edge
sprayed with an adhesive spray. The skin
edges are approximated and held with rein
forced Steri-Strips. In some patients, inter
rupted skin edge sutures that have been
placed and left untied at the time of opera
tion are used to facilitate the application
of the tape.
R esults
Type of Operation and Colon Disease
There were 179 operations on the colon.
Anterior resection was the most common
operation (Table I) and cancer the most
frequent diagnosis (Table II). There were
more operations than diagnoses because of
the number of colostomy closures. The ma
jority of colon operations were elective
(164) but among the 15 emergency opera
tions the proportion of wounds managed by
TABLE III.—W ound I nfection R elated

Vol. 19

Cancer of colon and rectum..............................
Diverticulitis......................................................
Ulcerative colitis................................................
Granulomatous colitis......................................
Ischemic colitis..................................................
Other...................................................................
Total....................................................

92
28
11
16
155

delayed closure was relatively higher (7 of
the 15) than among the elective operations
(45 of the 164) (Table III).
Incidence of Wound Infections
The wound infection rate was distinctly
lower in wounds closed secondarily than in
those closed primarily (Table III); the over
all incidence of 5.8% is similar to that often
reported for clean or clean-contaminated
wounds.4 With respect to the 164 elective
operations the wound infection rate with
delayed closure was lower still (4.4%); and,
as expected, the overall incidence of infec
tion was much higher for emergency opera
tions.
Wound Healing
To be certain that delayed closure by
tape did not adversely affect wound healing,
we determined the state of the wound at
discharge. For all colon operations, 12
(9.5%) of wounds closed primarily were
partially or completely open at the time of
discharge from hospital whereas only 2
(3.8%) of wounds closed secondarily were
open at the time of discharge.
Antibiotic Therapy
Approximately one-third of patients in
both main groups— primary and delayed
closure—had no antibiotics as part of

to U rgency of Operative P rocedure
Wound C losure

and

M ethod

of

Method of wound closure
Urgency of operation

Primary
(n = 127)

Elective, no. of procedures..........................
Wound infection, no. (and % )....................

12(10.1)

Emergency, no. of procedures.....................
Wound infection, no. (and % )....................

3(38)

Elective + emergency procedures.............
Wound infection, no. (and % )....................

15(11.8)

Delayed
(n = 52)

119
2(4.4)
8

Total
45
14(8.5)
7

1(14)
127

15
4(27)

52
3(5.8)

164

18(10.1)

179
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bowel preparation or in the immediate post
operative period. All other patients received
antibiotics systemically or orally as a pro
phylactic measure. Variations in the type of
antibiotic and the timing of administration
made reasonable analysis impossible. How
ever, wound infections occurred with equal
frequency in patients receiving and not re
ceiving antibiotics, and the use of antibiotics
was not different in the primary and delayed
closure groups.
D iscussion
The concept of delayed primary closure
of contaminated wounds is not new and
evidence has been presented to explain the
resistance of open wounds to infection.
Billroth3 applied virulent organisms to
dressings covering granulating wounds and
found that infection did not develop— but
the same experiment on fresh incised
wounds caused infections to develop; fur
thermore, if the granulating wound was
closed over an infecting inoculum of bac
teria, infection occurred. Edlich and collea
gues6 created wounds on the backs of
guinea pigs and found that when such
wounds were contaminated with Staphylo
coccus aureus, the optimum time of delayed
primary closure, without development of
wound infection, was on or after the 4th
postoperative day.
The number of bacteria contaminating
the wound was recognized to be clinically
important by French surgeons as early as
1917.7 For example, in World War I, war
wounds more than 15 hours old were debrided, cultured, flooded with Dakin’s solu
tion and packed open with flavine gauze.
The patient was then sent to the base hos
pital together with his culture plate. If no
streptococci had grown, and if there were
less than five colonies of other bacteria per
plate, the pack was removed and the wound
managed by delayed closure; if there were
more than five colonies on the plate, the
wound was left open and allowed to heal
by secondary intention. It is now known
that, in terms of tissue content, the critical
concentration of bacteria necessary to cause
wound infection is 105/g ,8 and skin-graft
survival is 94% if the concentration is
103/g or less, but lower than 20% if the
count exceeds 103/g.
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Robson and his colleagues9’ 10 reported a
retrospective study of delayed wound closure
with quantitative tissue cultures. They
studied 40 wounds, of which 20 were left
open for delayed primary closure and the
other 20 were closed primarily but reopened
to drain wound infections. Delayed primary
closure was then carried out for the latter
group. The time of delayed closure was
determined according to clinical criteria
alone, although bacterial counts were done
at the time of delayed wound closure. Of
30 wounds in which the tissue concentra
tion of organisms was less than 103/g, 28
healed without complication, but none of
the 10 wounds closed when the tissue bac
terial concentration was greater than 105/g
healed without infection.
Delayed primary closure was frequently
used during the Vietnam war, and for con
taminated wounds, Heaton and colleagues11
reported an infection rate with this technique
of 2.6% . A similar rate was reported for
civilian patients with perforated appendici
tis: Grosfeld and Solit1- found that delayed
primary closure decreased the wound infec
tion rate from 34% to 2.3% .
There is thus abundant evidence, from
the experience of military surgeons in at
least four major wars and from numerous
civilian studies, both clinical and experi
mental, that proves beyond reasonable
doubt that delayed closure decreases the in
cidence of infection in contaminated wounds.
Another factor is the use of antibiotics.
Whether antibiotic therapy can be used as
an alternative to delayed closure or as an
ancillary supportive measure with delayed
closure is not yet clear. Cruse and Foord13
could not show a decrease in the infection
rate of contaminated wounds from the
topical use of ampicillin and bacitracin. On
the other hand, Polk14 has shown in a
prospective study a decrease in the infection
rate of contaminated wounds with the sys
temic use of cephaloridine. Stone and
Hester13 have reported data suggesting
that delayed closure and antibiotic therapy
(local and systemic) are alternative methods
of lowering the infection rate in contamin
ated wounds of patients with perforated ap
pendicitis and traumatic perforation of the
intestine. In that study, the incidence of
wound infection with primary closure was
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60% , with delayed closure 20% , and with
antibiotics and primary closure 15% .
Whatever the role of antibiotics, there is
little justification in ignoring the evidence
for the value of delayed closure of con
taminated wounds. The results of this study
further support the argument for delayed
closure and emphasize the ease with which
this can now be accomplished with the use
of tape. It is possible that the lowest rate of
infection in contaminated wounds will be
achieved with both delayed closure and anti
biotics.
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DELAYED PRIMARY CLOSURE OF THE SKIN AND SUBCUTANEOUS
TISSUE IN ABDOMINAL SURGERY*
A. D. McLACHLIN, MD, MSc, DPhil(Oxon), MS(Tor), FRCS(Eng), FRCS[C], FACS and
W. WALL, MD, FRCS[C]
Summary: Infection-prone abdominal incisions
in 143 patients were managed by delayed primary
closure of the skin and subcutaneous tissue of
the abdominal wall. The overall wound infection
rate was 1.4% and the rate for 74 open, large
bowel operations was 2.7%. These rates com
pare favourably with a rate of 3.1% for clean
inguinal hernia repairs done by the same surgical
team over the same period. Delayed primary
closure, carried out on the ward 3 days after
operation, was simple, easy and did not prolong
hospital stay. Its use is recommended in closing
all abdominal wounds associated with a special
risk of infection.
Resume: Chez 143 malades enclins a I'infection
des incisions abdominales, nous avons procede
a la cicatrisation de la peau et du tissu souscutane par premiere intention retardee de la paroi abdominale. Le taux global de plaies infectees a ete de 1.4% et, dans 74 operations ouvertes du colon, de 2.7%. Ces taux se comparent
favorablement avec le taux de 3.1% pour des
herniorraphies de hernies inguinales faites par
la meme equipe chirurgicale durant la meme
periode. La cicatrisation par premiere intention
retardee, pratiquee dans la salle 3 jours apres
('operation a ete faite simplement, facilement
et n’a pas prolonge la duree de (’hospitalisation.
Nous conseillons cette methode dans tous les
cas ou existe un risque special d'infection.

T h e resistance of an open wound to infec

tion was demonstrated by Billroth in 1864.1
A wound with tissue loss in the back of a
dog was left open to develop a granulating
surface. Repeated applications of dressings
soaked in liquid feces or pus did not make
the wound appear infected and the dog re
mained healthy and without fever. But when
the contaminated dressings were sutured
into the wound, the wound edges soon be
came swollen, liquid feces entered the su
ture opening and fever developed. This basic
concept that an open wound is less likely
to become infected than a wound that has
been sutured primarily has often been re*From the department of surgery, University of
Western Ontario, London, Ont.
Reprint requests to: Dr. A. D. McLachlin, De
partment of surgery, University Hospital, 339
Windermere Rd., London, ON N6G 2K3.

vived, particularly in time of war.2 4 We
have used this principle in selected cases
since 1945r’ and have developed a method
of placing the skin sutures in position at
the initial operation, leaving them untied
until the time of delayed primary closure.
In 1972, the frequency of infection in the
subcutaneous tissue of the abdominal wall
following colon surgery led us to begin leav
ing the abdominal skin and subcutaneous
fat open in all patients undergoing large
bowel operations. Success with the method
then led to its use in other abdominal
wounds that were at special risk from in
fection.
P a t ie n t s , O pera tio n s and M e th o d s

Operations

Delayed primary closure of skin and sub
cutaneous tissue of the abdominal wound
was used in 143 patients from 1972 to 1974
inclusive (Table I); all procedures were per
formed by a single surgical team using estab
lished surgical techniques. The details of
the 74 open, large bowel operations are
summarized in Table II; mechanical cleans
ing and prophylactic systemic antibiotics
(ampicillin and penicillin) were used in this
group.
Of the 11 gastric operations 9 were
gastrectomies. Nine operations on the biliary
tract included common duct exploration and
another six were reconstructive procedures.
Of the 12 hernias treated by delayed primary
closure 6 were irreducible, with 5 strangula
tions; the rest were large or recurrent inciTABLE I.—Wound I nfection R ate

in I nfec 
tion -P rone Abdominal I ncisions in Operations
M anaged by D elayed P rimary C losure

Type of operation

No. of
patients

74
Large bowel, open. ..
24
Biliary tract..............
12
Hernia.......................
Stomach....................
11
5
Small bowel...............
17
Other.........................
143
Total..................
‘Wound infection rate, 1.4%.

No. of wound
infections
2
0
0
0
0
0
2*
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TABLE II.— W ound I nfection R ate in I nci
sions for

M anaged

Open , L arge B owel Operations
by D elayed P rimary C losure

Type of operation

No. of
patients

Closure of colostomy.
Right colectom y........
Anterior resection. . . .
T ransabdominal
polypectom y...........
Abdominoperineal
resection..................
Sigmoid colectom y...
Total colectom y.........
Left colectom y...........
Other............................
T otal....................

No. o f wound
infections

16
11
10

0
0
0

8

0

7
7
4
3
8
74

0
1
0
0
1
2*

Fig. 1.—Technique for delayed primary closure
of abdominal wounds. Note single layer of fine
polyester nonadherent dressing in depth of wound
holding skin and subcutaneous tissues apart.
Dressing is left undisturbed until time of delayed
primary closure.

*Wound infection rate, 2.7%.

sional hernias requiring extensive tissue dis
section. The 17 other operations included
appendectomy (3), drainage of pancreatic
pseudocyst (2), drainage of liver abscess (2),
enteroenterostomy (6), repair of liver in
jury (2), and splenectomy (2).
To estimate the rate of clean wound in
fection for comparison, wound infection
rates for all inguinal herniorrhaphies man
aged by immediate primary closure over the
same period by the same surgical team were
analyzed. There were 65 patients in this
group.
In accordance with the criteria established
by the National Research Council study,6 a
wound was considered infected if there was
a purulent discharge, whether or not organ
isms could be cultured from the purulent
material. The postoperative follow-up period
in all patients was long enough to rule out
late wound infections.

Skin sutures are removed on the 6th or
7th day, and the adhesive strips are often
removed at home by the patient about 10
days after operation. No special precau
tions in postoperative activity are necessary.
R esults

The wound infection rates relating to cus
tomary closure of wounds and delayed pri4

Surgical Technique

In the operating room after closure of
the fascia with stainless steel wire sutures,
4-0 cotton skin edge sutures are placed at
2-cm intervals and left untied. A sheet of
fine polyester nonadherent dressing placed
to the depth of the wound holds the skin
and subcutaneous tissue apart and a sterile
occlusive dressing is applied (Fig. 1). The
wound edges are not packed open but mere
ly held apart by the nonadherent dressing
until the 3rd postoperative day, when the
dressing is removed on the ward using
sterile technique and the wound closed
(Fig. 2). Mild sedation with meperidine and
diazepam relieves any discomfort.

on ward 3 days after operation. Gentle traction on
tied sutures approximates skin edges accurately
and makes application of tape easy; digital pres
sure during application of tapes helps obliterate
dead space.
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TABLE III.—Summary of W ound I nfection R ates of Abdominal I ncisions
No. of
patients

Type of primary closure
Delayed
All operations............................................................. ..........
Colon operations only.............................................. ..........
Immediate (clean inguinal herniorrhaphy)................... ..........

mary closure are summarized in Table III.
The two wound infections in the group of
patients managed by delayed primary
closure (overall incidence, 1.4%) both oc
curred in patients undergoing large bowel
surgery (incidence in large bowel operations,
2.7%). One infection occurred 5 days after
sigmoid colectomy; removal of two sutures
and drainage were required. Culture grew
Escherichia coli. The other infection was
obvious when the dressing was removed in
preparation for delayed primary closure.
The patient, who was morbidly obese, had
undergone transverse colectomy. The open
wound drained a green purulent discharge,
which yielded Pseudomonas organisms on
culture and was left to close by secondary
intention. In neither patient was the infec
tion invasive and in both the wound healed
satisfactorily.
Among the 65 patients undergoing in
guinal herniorrhaphy during the same period
there were two wound infections (clean
wound infection rate, 3.1% ). Both cases
of infection occurred in patients who had
undergone repair of recurrent hernia; puru
lent discharge, noted at 7 and 10 days re
spectively, yielded growth of Staphylococcus
aureus on culture.
D iscussion

Various techniques of delayed primary
closure have been described for the man
agement of abdominal wounds in the pres
ence of contamination.7'9 Irrigating solu
tions and topical antibiotics have been used.
The recommended interval between opera
tion and delayed primary closure has been
as long as 10 days. We have closed the
wounds on the 3rd postoperative day and
have found topical antibiotics and wound
irrigation unnecessary. The amount of clot
ted blood left in the wound when the initial
dressing is removed is usually insignificant
and is left undisturbed. Rarely, larger clots

143
74
65

No. of
infections
2
2
2

Wound infection
rate, %
1.4
2.7
3.1

have required removal before the wound is
closed.
Closure of wounds on the ward has not
distressed patients. Wounds in patients with
a high risk of infection closed in this manner
have manifested less local swelling and have
seemed “quieter” than wounds closed with
vertical mattress sutures or with buried su
tures in the subcutaneous fat.
Delayed primary closure of wounds
shortened the operating time and made less
necessary the need for meticulous control
of fine bleeding points compared with im
mediate primary closure of the subcutaneous
fat and skin. There was no delay in dis
charge of patients from hospital and the final
appearance of the incision was satisfactory.
The low wound infection rate of 2.7%
obtained in open colon surgery by manag
ing wounds in this manner is encouraging in
view of the reported incidence of 8.9% to
21.5% in clean-contaminated and conta
minated cases, respectively.10
C o n c l u sio n

Delayed primary closure of abdominal
wounds is simple and easy for the surgeon
and well tolerated by the patient. Infection
rates for incisions of abdominal operations
of 1.4% overall and 2.7% for large bowel
procedures in comparison with a rate of
3.1% for clean inguinal herniorrhaphies
managed by immediate primary closure are
encouraging. Hospital time is not prolonged
and the appearance of the healed wound is
good. General satisfaction and success with
this method in colon surgery has led us to
broaden its indications, and we are now
using delayed primary closure in most ab
dominal wounds that seem to have a special
risk of infection.
R eferences

1. Billroth T: Beobachtungs—Studien iiber
Wundfieber und accidentelle Wundkrankheiten. Arch Klin Chir 6: 443, 1865

40

THE CANADIAN JOURNAL OF SURGERY

2. K irk NT: Circular Letter No. 91, US War

Department, Army Service Forces, Office
of Surgeon General. Apr. 26, 1943
3. H eaton LD, H ughes CW, R osegay H, et al:
Military surgical practices of United States
Army in Vietnam. Curr Probl Surg 19,
November 1966
4. W ilson H: Secondary suture of war wounds;
clinical study of 305 secondary closures.
Ann Surg 121: 152, 1945
5. M cL achlin AD: Delayed primary suture in
surgical management of diabetic gangrene.
Proc Am Diabetes Assoc 7: 271, 1948
6. N ational A cademy of Sciences-N ational
R esearch C ouncil: Evaluation of infec

Vol. 19

tion. Ann Surg 160 (suppl): 22, 1964
7. H udspeth AS: Elimination of surgical wound
infections by delayed primary closure.
Southern Med 1 66: 934, 1973
8. C arroll EL, T urnbull RB: Prevention of
abdominal wound abscess in intestinal
surgery: ongoing study of delayed wound
closure. Rev Surg 29: 295, 1972
9. G rosfeld JL, Solit RW: Prevention of
wound infection in perforated appendicitis:
experience with delayed primary wound
closure. Ann Surg 168: 891, 1968
10. C ruse PJ, F oord R: Five-year prospective
study of 23,649 surgical wounds. Arch
Surg 107: 206, 1973

DAVIS & GECK SURGICAL ESSAY AWARD
FOR RESIDENTS
The Canadian Journal of Surgery announces the institution of an award of $1000.00
for the best paper on a surgical topic submitted by a surgical resident. To be given annu
ally by Davis & Geek, this award is intended to promote scientific and literary excellence
among Canadian surgeons in training. The first award will be presented in 1976.
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The conditions of entry for the award for 1976 are the following: —

V*

1. Candidates shall be currently engaged in a recognized surgical residency program
leading to eligibility for the Fellowship of the Royal College of Physicians and
Surgeons of Canada in one of the surgical specialties (cardiovascular and thoracic
surgery, general surgery, neurosurgery, obstetrics and gynecology, ophthalmology,
otolaryngology, orthopedic surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript relating to
work in which a surgical resident is or has been the prime or major investigator.
Prior oral presentation at a Royal College meeting or a Surgical Forum meeting
will not be a disqualification, but prior publication as a formal paper in a
journal will. The paper should relate to any field of surgical interest. The manu
script must conform to the style requirements of the Journal and must not
exceed 3000 words of text and six tables and/or six figures.
Coauthors are permitted on the understanding that the candidate shall be the
first author and that only the first author shall be eligible for the award.
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A
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3. Entries must be received in the office of the Journal no later than June 30, 1976.
Each entry must be submitted to Dr. D. A. E. Shephard, MB, FRCP(C), at the
office of the Canadian Journal of Surgery, P.O. Box 8650, Ottawa, Ontario,
K1G 0G8, with a letter stating that the paper is being submitted as an entry
for the Davis & Geek Essay Award.

A

4. The award-winning paper shall be published in the Canadian Journal of Surgery
and shall be the property of the Journal.
All papers submitted will be judged by an independent committee comprising at
least one member of the editorial board of the Journal, one Fellow of the Royal College
of Physicians and Surgeons of Canada, and one representative of The Canadian Medical
Association, together with other Fellows invited to serve at the discretion of the three
permanent members of the committee. For the purpose of judging, the candidates will
be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be announced
in the November 1976 issue of the Journal.
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SUBMUCOUS LIPOMA OF THE STOMACH: A CASE REPORT*
N. R. KALLIE, BSc, MB, ChB, DCP(Lond), DPath(Lond), FRCP[C1,
J. A. M. PETERS, MD, FRCS[C] and S. C. CHOW, MD, FRCP[C]
Summary: A 54-year-old woman presented with
a 4-day history of melena and a 1-day history
of hematemesis. Radiographs were suggestive
of a malignant gastric polyp. Gastrotomy re
vealed a polyp projecting from the anterior wall
of the stomach. The polyp was excised and
the patient has since been well. Although rare,
gastric lipomas are important because they may
cause hemorrhage, abdominal pain, dyspepsia
and pyloric obstruction; moreover, they are
amenable to surgical treatment.
Resume: line femme de 54 ans s'est presentee
a I'hopital avec les symptomes suivants: melena
depuis 4 jours et hematemese depuis 1 jour.
Les radiographies laissaient supposer la pre
sence d'un polype gastrique malin. line gastrotomie a revele un polype faisant saillie en
dehors de la paroi anterieure de I'estomac.
Le polype ayant ete excise, la malade est,
depuis, bien portante. Bien que rares, les lipomes gastriques ont une importance incontes
table, parce qu'ils entrainent des hemorragies,
une douleur abdominale, de la dyspepsie et une
occlusion du pylore. Du reste, ils peuvent etre
operes.

Since Virchow’s initial report of a gastric
lipoma, found during an autopsy in 1863,1
157 cases have been documented.2 Gastric
lipomas are rare—benign tumours of the
stomach constitute only 1% of all gastric
neoplasms and of these 3% are gastric
lipomas3—but they are important because
of complications such as hemorrhage, abdo
minal pain, dyspepsia and pyloric obstruc
tion4 and because they are amenable to
surgical treatment, in contrast to most
malignant neoplasms of the stomach. We
report a case of gastric lipoma with melena
and hematemesis as the presenting features
and in which surgical treatment was curative.

came weak, dizzy and pale. Her past history
contributed no relevant information.
The patient was pale and obese (103 kg).
Her blood pressure was 130/90 mm Hg and
her pulse rate was 96 beats/min; her admis
sion temperature was 37.4°C and her respira
tory rate was 20 /min. Abdominal palpation
revealed epigastric tenderness but no masses.
Rectal examination disclosed only tarry stool
on the examining finger. Other physical find
ings were normal. Results of laboratory inves
tigations were as follows: Hemoglobin concen
tration, 10.3 g/dl; hematocrit, 30%; leukocyte
count, 8.3 x 109/ / (80% polymorphonuclear
cells); fasting blood glucose value, 129 mg/dl;
blood urea nitrogen value, 39 mg/dl; serum
electrolyte concentrations (mmol//), normal
(sodium, 130; potassium, 4.4; and chloride,
104); and urinalysis, normal. As a result of
transfusion of 5 units of blood during the first
3 days of treatment the hemoglobin concen
tration increased to 12.2 g/dl.
Radiographic examination (Fig. 1) visualized
a large irregular sessile mass projecting into
the upper part of the lesser curvature of the
barium-filled stomach. The tumour, which had
a definite outline and was translucent, tended
to move with a change in the position of the
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C ase R eport
A 54-year-old woman was admitted to hos
pital with a 4-day history of tarry stools, which
had culminated in an episode of severe hema
temesis on the day before admission; she be-
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*From the Norfolk General Hospital, Simcoe,
Ont.
Reprint requests to: Dr. N. R. Kallie, Pathologist,
Norfolk General Hospital, Simcoe, ON N3Y 1T7.

F,g- 1-—Large irregular sessile mass projecting
into upper part of lesser curvature of bariumfilled stomach.
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Fig. 3.—Longitudinal section through polyp re
vealing pale-yellow, soft, greasy, lobulated fatty
tumour in submucosal region.

away from the ulcer sites was normal.
Fig. 2.—Gastric polyp covered by cobble-stone stomach
The patient has been in good health since
mucosa. Arrow indicates one of four ulcers found.
Note submucous fatty tumour exposed at sites of she was discharged from hospital on the 15th
incisions.
day.
patient. The pattern of the stomach was other
wise normal and no abnormalities were noted
in the esophagogastric junction and the duo
denum.
Continued gastric hemorrhage made laparo
tomy necessary. Through an upper abdominal
incision and a gastrotomy in the anterior wall
of the stomach, a gastric polyp was seen
projecting from the posterior wall midway be
tween the cardia and the pylorus. The polyp
( 8 x 6 cm) was excised at its base. There
were no other abdominal visceral abnormal
ities.
Macroscopic examination (Fig. 2) revealed
four benign ulcers on the surface of the polyp,
the diameter of the largest being 2 cm. The
ulcers were characteristically “punched out”
with sharply defined margins. The edges were
not raised. The mucosa of the remainder of
the polyp had a cobble-stone appearance and
was pink. A longitudinal section through the
polyp disclosed a pale-yellow, soft, greasy,
lobulated fatty tumour in the submucosal re
gion (Fig. 3).
Microscopic examination showed that the
beds of the ulcers were covered by fibrinous
exudates containing fragmented leukocytes,
and the bases were fibrotic and contained
lymphocytes, plasma cells and a few eosino
phils. The muscular coat manifested general
ized fibrosis. The submucosal region was re
placed by adult adipose tissue, some areas
containing foam cells and fibrous tissue trabeculations containing small blood vessels
were scattered throughout the tumour. A diag
nosis of submucous lipoma of the stomach was
made (Figs. 4 and 5). The mucosa of the

D iscussion

Lipomas may arise in practically any body
tissue. They are the second most common
benign tumour of the gastrointestinal tract,
myomas being more common. They evi
dently develop in adults of both sexes6' 7
and of all ages; Turkington4 reported an
age range from 29 to 83 years. Weinberg and
Feldman5 noted that they occur with greater
frequency among diabetics.
Gastric lipomas have four outstanding
clinical features— hemorrhage (which may
be fatal), abdominal pain, dyspepsia and
pyloric obstruction.4 Hemorrhage is the pre
senting feature in about 50% of the re
ported cases.4' 8-111 The characteristic radiographic features of the condition, well docu
mented by Moore,11 are a circumscribed,
punched-out filling defect, usually not on
the curvatures; a relatively normal appear
ance of the rugae; and lack of evidence for
emptying of stomach and for spasm. The
patient whose case we report presented with
hematemesis and had a high fasting blood
glucose (129 mg/dl) but the typical radiographic features were not clearly demon
strated; the diagnosis of a malignant neo
plasm was considered.
Over 60% of gastric lipomas are found
in the antrum of the stomach.1- 4- 5> 12, 13
Tumours located near the cardia cause dys
phagia and those near the pylorus are liable
to produce obstruction.1- 4 1 4 The incidence
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of ulcers associated with gastric lipomas is
reportedly 33% .15 Usually the mucosa
overlying the tumour is unremarkable; 95%
of all gastric lipomas are submucous and
the others are subserous;1- 3 12 the tumour
itself is yellowish, soft, greasy and lobulated.4- 10 The histologic appearance is that
of normal adipose tissue.
Malignant degeneration is not a feature
of gastric lipomas,4' 1 617 and liposarcomas
of the stomach are almost unknown; how
ever, when they do occur they are malig
nant ab initio.
Various views have been put forward
with regard to the origin of gastric lipoma.18
Some believe that it arises from a fetal
anlage separated during fetal life, and others
believe that chronic irritation results in lowgrade inflammation and hypertrophy with
subsequent tumour formation. The latter
view is not substantiated, because of the
absence of inflammation and of metaplasia
in most cases.
We thank Miss Cindy Maxwell for typing the
manuscript, Mr. B. Cook and Dr. K. Shier for
preparing the illustrations, Mrs. M. Carpenter
for collecting the references and Dr. S. Moore
for valuable criticism.
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ACUTE PERFORATION OF THE COLON*
A. A. LOZON, MD, FRCS[C] and J. H. DUFF, MD, FRCS[C]
Summary: Acute perforation of the colon causes
P er fo r a tio n is a life-threatening complica
fecal peritonitis, which is associated with high
tion of most diseases of the colon and
rates of morbidity and mortality. Findings in
occurs
in patients of all ages. Acute perfo
78 patients with perforation of the colon showed
that the commonest causative condition was ration causes fecal peritonitis, which may be
diverticulitis fin 42%) and that the commonest localized or diffuse. Despite aggressive sur
site was the sigmoid colon (in 65%). The over gical and medical management, fecal peri
all mortality in this series was 49%, most of tonitis is associated with high rates of mor
the deaths being due to peritonitis; the extent bidity and mortality. The aim of this study
of anatomic spread of peritonitis was a major was to ascertain the incidence and sequelae
factor. The form of treatment was also a factor of perforation of the colon and to deter
in mortality: mortality was lowest in patients mine whether morbidity and mortality could
treated by diversionary colostomy (only 38%)
be related to various methods of surgical
and highest in those treated by exteriorization management.
of perforation (71%) and in those not treated
operatively (71%). With respect to postoperative
M ethod
complications in patients who underwent oper
ation, wound infection and pulmonary abnormal
The charts of all patients with perfora
ities each occurred in 50%. This review suggests
that current methods of management of patients tion of the colon treated from 1963 through
1972 were reviewed retrospectively. During
with perforation of the colon are less than
the same period the total number of pa
satisfactory.
Resume: La perforation aigue du colon cause une
peritonite fecale laquelle s'accompagne d'une
proportion considerable de morbidity et de mor
tality. Apres avoir passe en revue les dossiers de
78 malades ayant presente une perforation du
colon, nous avons decouvert que I'etiologie la
plus courante etait la diverticulite (soit chez
42% des cas) et que le siege principal etait
le colon sigmoide (dans 65%). Dans cette serie
de patients le taux total de mortality etait de
49%, la plupart des deeds etant attribuable a
la peritonite; le degre de la propagation anatomique de la peritonite representait un facteur
capital de gravite. La forme du traitement a
egalement joue un role dans la mortality, qui
etait minimale chez les patients traites uniquement a moyen d’une colostomie de deriva
tion (38%), et maximale chez ceux qui avaient
subi une exteriorisation de la perforation (71%)
ainsi que chez les patients non operes (71%).
En ce qui concerne les complications postoperatoires, I infection de la plaie est apparue chez
50% des cas et des anomalies pulmonaires sont
apparues egalement chez 50% des cas.

*From the department of surgery, Victoria Hos
pital, and University of Western Ontario, London
Ont.
Reprint requests to: Dr. J. H. Duff, Department
of surgery, University Hospital, 339 Windermere
Rd„ London, ON N6A 5A5.

tients admitted with injury or disease of the
colon was determined. All cases of perfo
rated colon were included if the diagnosis
was confirmed by operation or autopsy.
R esu lts

Incidence, Age and Extent of Peritonitis
Of 1020 patients admitted to hospital
with a disorder of the colon 78 (7.6%) had
sustained a perforation. There were 41 men
and 37 women; the average age was 54.9
years, most being between 40 and 79 years
old. For these 78 patients findings at oper
ation or autopsy showed that 30 had a
perforation with localized peritonitis and
that 48 had perforation with diffuse peri
tonitis.
Clinical Features
Fever was noted in 96% of patients.
Radiographs (plain films and barium enema)
were obtained in 61 (78.2%) of the pa
tients; free air was visualized in 30% of
these patients and barium enema was diag
nostic of perforation in 34%. Although
barium enema was contraindicated when
the diagnosis of perforation of the colon
was obvious, it was useful and extremely
accurate when the diagnosis was in doubt.
In 21 of 25 patients barium enema was diag-
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nostic of perforation. Overall, radiographs
provided a definitive diagnosis or were help
ful in 36% of patients. Only 15 patients
(19% ) underwent sigmoidoscopy and in only
5 was it helpful in determining the type of
colorectal disease causing perforation.
Cause and Site of Perforation
The commonest cause of perforation of
the colon was diverticulitis; this was the
causative factor in 42% of patients. Ische
mic colitis was the cause in 14%, trauma
in 13%, perforating carcinoma in 9% ,
obstruction in 8% and radiation necrosis
in 4% . Less common causes were ulcera
tive colitis (2 patients), volvulus (2), gastro
colic fistula (1) and stercoral ulceration (1).
Together the latter conditions accounted for
7.6% of perforations. Of the 11 patients
with ischemic colitis, 4 had nonocclusive
ischemia,1 3 had atherosclerotic vascular
occlusion, 3 had undergone aortic resection
before the perforation developed, 1 had
sustained traumatic interruption of the vas
cular supply as a result of a motor vehicle
accident. As Fig. 1 shows, perforation oc
curred most frequently in the sigmoid colon.
In two patients sigmoidoscopy was the cause
of the perforation.

TABLE I.—Organisms C ultured

in

Organism

Proportion (%)
of patients
with organism

Escherichia coli .......................
Clostridia sp,...........................

52 P atients

69
19
19
15
12
12
10

Anaerobic streptococci.........
Pseudomonas sp......................
Bacteroides sp.*......................
Klebsiella sp............................
Proteus sp................................
*For 1969 onwards.

Bacteriologic Findings and Antibiotic
Therapy
Bacterial cultures were obtained in 52
patients; Escherichia coli was the organism
cultured most frequently (Table I). Anti
biotics were given to all but five patients.
Ampicillin, chloramphenicol and gentamicin
were the most commonly used, though since
1969 chloramphenicol has been given infre
quently and gentamicin more frequently.
Mortality
Overall, there were 3 8 deaths in the series
(mortality, 49% ); 34 deaths were due to
peritonitis (which included septic shock and
impaired nutrition), 2 were due to pulmon
ary embolism and 2 due to associated in
juries from trauma (Table II).
TABLE II.—C ause of D eath
Cause of death

Peritonitis...............................
Pulmonary embolism............
Associated injury..................
Total...............................

in

38 P atients

No. of patients

34
2
2
38

Of the 78 patients, 71 underwent an
operative procedure and 33 of them died.
The mean duration between operation and
death was 11 days. Seven patients did not
undergo operation, and, five of these pa
tients died. In two patients perforation
was caused by a diagnostic barium enema
and in one perforation was due to radiation
necrosis. The only survivors of the group
who did not undergo operation were the
two patients in whom perforation developed
during a barium enema.
Site of perforation and mortality.—
Among the 51 patients in whom the sigmoid
colon was perforated, 19 (38% ) died, and
among the 19 patients with perforations of
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TABLE III.—M ortality
Causative condition
Diverticulitis............
Ischemic colitis........
Trauma.....................
Carcinoma................
Obstruction with
perforated cecum.
Radiation necrosis. .
Others.......................
Total.................

of

No. of
patients

C olon P erforation
No. of
deaths

33
11
10
7

8
10
7
4

Mortality,
%
24
91
70
57

6
3
8

2
3
4

33
100
50

78

38
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TABLE V.—P ostoperative Complications
C olon P erforation

of
*•

Complication

No. (and %)

36 (50)
Wound infection................................
Localized peritonitis and abscess 11
Diffuse fecal peritonitis............... 25
Lung lesion.........................................
35 (49)
Septicemia..........................................
12 (17)
Wound dehiscence............................
4 (6)
Small bowel fistula..........................
2 (3)

*C

treated by resection and diversion was sur
prisingly high (50%).

the cecum and ascending colon 12 (63%)
Postoperative Complications
died.
The complications of perforation of the
Cause of perforation, peritonitis and mor
tality.— Details of mortality in relation to colon are listed in Table V. Wound infec
the cause of perforation are summarized in tions and lung lesions were found in half
Table III. The extent of anatomic spread of the patients and septicemia occurred in
of peritonitis was a major factor in mortal nearly one-fifth. Radiologic diagnoses of the
ity. In the group of 30 patients who had lung lesion included pneumonia, pulmonary
perforation with localized infection or congestion, pleural effusion and atelectasis.
abscess formation, 7 (23% ) died, but of Though likely to have been present, shock
48 patients with diffuse peritonitis, 31 lung was not diagnosed during the time of
this review.
(65% ) died.
Treatment and mortality.— Details of
D iscussion
mortality in relation to operative manage
This study has shown that a wide variety
ment of patients with perforation of the
colon, particularly with regard to resection of diseases of the colon are severe enough
of the septic focus (perforation) and per to require admission of patients to hospital.
formance of a diversionary procedure are Perforation is the most grave complication
presented in Table IV. Mortality was low of all of these diseases. The incidence in
est in patients in whom only a diversionary this study of perforation of hospital admis
colostomy was performed; most of these sions for colon diseases (7.6%) was sur
prisingly high. But Watkins and Oliver2
patients had diverticulitis.
reported
an incidence of 14% among pa
Since the primary pathologic lesion dif
fered among treatment groups, a statistical tients entering hospital with diverticulitis,
comparison of mortality rates for different and Goligher2 reported an incidence of per
methods of surgical treatment is not valid. foration among patients with ulcerative
None the less, it is evident that for all meth colitis ranging from 5 to 9% depending on
ods of surgical management, the mortality the severity of the first attack. In toxic
was unacceptably high. Mortality of patients megacolon few patients survived perforation
regardless of treatment, but when operation
is
performed before perforation occurs, mor
TABLE IV.—M ortality of C olon P erforation
tality approaches that of elective colon re
No. of No. of Mortality,
section.2 In the patients whose cases were
Treatment
patients deaths
%
reviewed in this study, perforation was
Diversionary colosobviously a turning point in their disease
tomy only............
34
12
35
from which only 50% survived. Diverticu
Resection of
litis and obstruction were the only condi
perforation...........
24
12
50
Exteriorization of
tions in which the mortality of perforation
perforation...........
7
5
71
was less than 50% .
Drainage only..........
6
4
67
The surgical approaches to perforation
No operation............
7
5
71
of the colon include peritoneal lavage,
Total.................
78
38
49
exteriorization of the perforated segment,

4

*
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defunctioning proximal colostomy and, more
recently, resection of the perforated segment
with end-to-end anastomosis. The latter ap
proach has merit because it permits removal
of the source of peritoneal contamination,
which may continue to leak fecal material
despite proximal defunctioning. Madden and
Tan4 reported an improved survival in pa
tients with diverticulitis if the involved area
was resected. In contrast, the findings of
our study fail to support this approach:
defunctioning colostomy alone was associ
ated with the lowest mortality rate. Although
the retrospective nature of the study and
the varied causes of perforation make stat
istical comparison invalid, it is clear that
resection or exteriorization of the perfora
tion was associated with an unacceptably
high mortality, for 17 of 31 died.
Wound infection was the most frequent
complication of perforation of the colon,
occurring in over half the patients who had
diffuse peritonitis. This finding strongly sug
gests that skin closure should be abandoned
in such patients in favour of secondary clos
ure when the open wound is granulating
and clean. In a recent review of wound
infection in elective and emergency colon
surgery, we found that 10% of wounds
closed primarily became infected in contrast
to only 4% in wounds packed open and
closed secondarily by tape (unpublished
data).
Our bacteriologic findings are very sim
ilar to those of Storer.'1 Before 1969, anae
robic cultures were not carried out routinely,
thus all Bacteroides infections were diag
nosed since 1969. Therefore, the true inci
dence of Bacteroides infection is likely
higher, as suggested by Beazley, Polakavetz
and Miller.0
The incidence of lung complication was
high (49%) but this finding supports work
emphasizing the prevalence of lung lesions

51

in septic conditions.7 Though impossible to
say in retrospect, present experience with
peritoneal sepsis suggests that many of the
pulmonary lesions observed would fulfil the
criteria for the lung lesion of sepsis. This
pulmonary complication is refractory to cur
rent methods of treatment and often a direct
cause of death in such patients.
C o n c lu sio n

This review suggests that the currently
accepted methods of management for per
foration of the colon are less than satisfac
tory. At best, surgical treatment is only
slightly better than conservative treatment.
Moreover, mortality associated with various
methods of surgical management is high.
Thus, while anatomical cure is possible and
usually accomplished without great diffi
culty, the patient fails to survive because
of the general effects of sepsis, one of which
is pulmonary edema. Because prevention of
colon perforation is frequently not possible,
new approaches to this complication will be
required to improve survival.
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DEXON: AN EXCELLENT SUTURE FOR MIDLINE INCISIONS*
D. M. GRACE, MD, FRCS[C]
Summary: In a period of 18 months, 100 midline
incisions of 93 patients w ere closed with inter
rupted 0 Dexon sutures. The Smead-Jones farand-near stitch was used. There were no early
disruptions and no incisional hernias in follow
up periods ranging from 5 days to 14 months.
Four wound infections healed readily without
prolonged drainage. Incisional pain was minimal
in all patients. A group of 18 patients with po
tential for poor healing because of hemorrhage,
sepsis, malignancy and steroids had no wound
complications apart from an acceptable rate of
infection. It is concluded that interrupted 0
Dexon with wide fascial placement provides an
excellent closure for midline incisions.
Resume: Sur une periode de 18 mois, nous avons
ferine 100 incisions medianes chez 93 patients,
au moyen de sutures interrompues de Dexon 0.
Nous avons, a cet effet, utilise le point de
Smead-Jones. Sur une periode de post-observa
tion variant de 5 jours a 14 mois, nous n'avons
constate ni rupture precoce ni hernie incisionelle. Quatre cas de plaies infectees ont gueri
rapidement sans long drainage. La douleur, au
niveau de I'incision a ete minimale chez tous
nos patients. Un groupe de 18 malades, dont le
pronostic de guerison etait mediocre, en raison
d’hemorragie, d'infection, de tumeurs malignes
et d'emploi de corticoides n’ont eu aucune com
plication sauf un certain degre, tres acceptable,
d'infection. Nous croyons done pouvoir conclure
que la suture interrompue avec le Dexon 0,
constitue un excellent moyen de fermer les in
cisions medianes.

A variety of sutures and incisions may be
used with good results in abdominal opera
tions, but no one method is perfect. Trans
verse incisions are useful and comfortable,
especially for obese patients, but operating
time and blood loss may be greater than
with vertical incisions. Midline incisions
offer the benefits of rapid entry, minimal
blood loss and extensibility. With respect to
sutures, stainless steel wire provides secure
closure of midline incisions but can cut
through fascia, and there is greater wound
’ From the department of surgery, University Hos
pital and University of Western Ontario, London,
Ont.
Reprint requests to: Dr. D. M. Grace, Depart
ment of surgery, University Hospital, 339 Windermere Rd., London, ON N6A 5A5.

discomfort, especially in thin active people;
nonabsorbable sutures such as silk handle
well and give initial security but may lead
to wound sinuses and late hernias if infec
tion occurs; and chromic catgut shows great
variation in absorption, especially in the
presence of infection, and is not reliable
enough for secure closure of midline inci
sions.
Initial experience with polyglycolic acid
(Dexon) suggested that it might offer no
advantages over chromic catgut1- 2 but sub
sequent experience has shown that Dexon is
satisfactory for abdominal incisions.3- 4 It
has been used for a variety of incisions and
we have found it to be satisfactory for ver
tical or transverse abdominal incisions.
There is a clinical suspicion that vertical
incisions do not heal as well as transverse,
and many surgeons are reluctant to use ab
sorbable sutures for midline incisions. In
this paper we report our initial experience
with Dexon in the closure of 100 midline in
cisions in operations on 93 patients. We also
report results of a more detailed study in
18 poor-risk patients in this group to demon
strate both wound security and comfort.
P atients and M ethods

A total of 100 midline incisions in 93
patients (age range, 6 to 85 years) were
closed with Dexon between the first use of
this method in December 1973 and May
1975 (Table 1). Five patients had two oper
ations through the same midline incision
with closure by Dexon and one had three
TABLE I.—T ypes
M idline I ncisions

of Operations in
were C losed with
Sutures

Type of operation
Biliary tra c t.........................
Large bowel.........................
Stomach................................
Laparotomy.........................
Splenectomy........................
Hiatus hernia......................
Small bowel.........................
Abscess drainage.................
Pancreas...............................
Miscellaneous......................
T o tal........

which

D exon

No. of operations
33
16
15
13
9
3
3
2
1
5
100*

’These 100 operations were performed on 93 patients.
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TABLE II.—P oor-R isk P atients
Patient
no.

Age
(yr)
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Comment

Procedure

i

30 Splenectomy

2

27

3

21

4

70

Hartmann procedure

5

25

Vagotomy, pyloroplasty,
oversewing bleeding
duodenal ulcer

6
7

74 R. colectomy
57 Splenectomy

8

32

9

48 Subtotal colectomy

Colectomy, proctectomy,
ileostomy
Drainage of pancreatic
abscess

Appendectomy

10

75 Hartmann procedure

11

49

Exploration of common
bile duct

12

63

Small bowel resection

13
14
15

57 Vagotomy, pyloroplasty,
oversewing bleeding
duodenal ulcer
20 Laparotomy
73 R. colectomy

16

41

Closure of perforated
duodenal ulcer

17

64

18

25

Repair of bile duct
stricture
Closure of perforated
gastic ulcer

I ncisions C losed

by

D exon

Wound
complications

None
Idiopathic thrombo
cytopenic purpura,
on steroids
None
Ulcerative colitis,
on steroids
None (DPC)*
Large lesser sac abscess
grew Staphylococcus
sp. and Clostridium sp.
Perforated diverticulitis, None (DPC)
peritonitis; on steroids
for asthma
Renal transplant; steroids None
and azathioprine;
hemoglobin, 2.7 mg/dl,
albumin, 1.4 g/dl
None (DPC)
Cecal volvulus, diabetic
None
Obese, cirrhotic,
hypersplenism
Infection,
Perforated appendix,
cleared well
peritonitis, septic
shock
None (DPC)
Brain tumour (on ster
oids), splenic flexure
carcinoma, gangrenous
cecum
Perforated diverticulitis, None (DPC)
rheumatoid arthritis; on
steroids
None
Carcinoma of common
duct; postop. radio
therapy
None (DPC)
Perforated Meckel’s
diverticulum; old TB,
thoracoplasty; respi
rator for 4 d
None (DPC)
Hemoglobin, 2.9 g/dl;
severe multiple
sclerosis
None
TB peritonitis
Large bowel obstruction, None (DPC)
gangrenous cecum
None (DPC)
Massive peritonitis, re
current brain tumour;
on steroids
None (DPC)
Cholangitis, hepatic
duct stricture
Infection,
Ulcer perforated 48 h,
healed well
ulcerative colitis; on
steroids

Follow-up
period

1 yr
14 mo
10 mo
3 mo
1 yr

6 mo
10 mo
13 mo
3 mo

5d
(died)
10 mo
(died)
3 mo

6 mo
3 mo
6 mo
7d
(died)
3 mo
2 mo

*DPC — delayed primary closure.

operations. During the initial 6 months of
the study, incisions in a number of poorrisk patients were closed with stainless steel
wire, but as confidence in Dexon increased
it was used more often until all midline in
cisions from May 1974 through May 1975
were closed with this suture. Particular at
tention to wound healing was paid in a
subgroup of 18 poor-risk patients (Table
II). Subcostal incisions for cholecystectomy
were used frequently during the initial
months of the study and were closed suc
cessfully with Dexon, but these cases have

been excluded. Later, most cholecystec
tomies were performed through midline in
cisions, and were closed with Dexon.
Data for all midline incisions, whether new
or through an old incision, have been in
cluded, except for those for midline inci
sional hernias closed with stainless steel
wire.
The method of closure was a modification
of the stainless steel wire technique used
successfully at this centre by Dr. A. D.
McLachlin for many years. The peritoneum
is first closed with continuous 2-0 chromic
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1.5 cm apart. The Smead-Jones5 type of
far-and-near technique is used (Figs. 1 and
2): the initial wide bite of the fascia is at
least 2 cm from the edge for secure holding
power and the second bite takes about 0.5
cm of fascia, the initial placement in each
case being on the side away from the oper
ator. Each stitch is held up with a Kocher
clamp to facilitate placement of the next
and to prevent penetration of underlying
peritoneum. All sutures are placed before
they are tied; to prevent slipping, a twohanded tie is used and a double throw is
used first followed by three square knots.
The skin is closed by means of any usual
technique, though we have lately used de
layed primary closure for incisions in many
contaminated or dirty cases. In these cases
the subcutaneous tissues are lined with
rayon and the wounds taped closed at 5 days
or when clean.
R e su lt s

r
4

As have others,6 we found Dexon to be
stronger than chromic catgut of the same
calibre. Because Dexon is relatively inelastic
and braided it tends to cut through soft tis
sues and is not suitable for closure of the
Fig. 1.—Method of closure of midline incision peritoneum; we found, however, that it did
with Smead-Jones far-and-near stitch. Peritoneum not show this tendency after wide placement
in lower incision is usually not closed as separate
in fascia. Handling was good and its knot
layer.
ting characteristics, though not as good as
catgut. Interrupted 0 Dexon is then used those of silk, were considerably better than
for closure of the fascia. Sutures (length, polypropylene. Dexon knots did have some
46 cm) are double-threaded on a large atrau tendency to slip, but the two-hand tech
matic disposable needle and placed 1 to nique with an initial double throw prevented
this problem.
There were no early instances of wound
disruption and no incisional hernias devel
oped during an average follow-up period of
6 months (range, 5 days [in a patient who
died from peritonitis] to 14 months). We
were initially concerned about the holding
power of Dexon in all patients, especially
those with sepsis, bleeding or malignant
neoplasms and those taking steroids. The
clinical details of a group of 18 patients in
whom impairment of healing might have
been expected are summarized in Table II.
There were no early wound disruptions or
late hernias in this group. Two wound in
Fig. 2.—Cross-section of abdominal wall show
fections
cleared readily with appropriate
ing placement of far-and-near stitch. Wide su
treatment.
ture often passes through rectus muscle.

r

r* -
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TABLE III.—C lassification
I nfections
Classification*
Clean...........................
Clean-contaminated..
Contaminated............
Dirty...........................
Total..........

of

No. of
incisions
55
18
17
10
100

W ounds

and

No. (and %)
of infections
1
1
o
2
4

(1.8)
(5.6)
( 0)
(20)
(4)

♦Criteria of National Research Council study.7

The incidence of wound infection is sum
marized in Table HIT The infection in the
one clean case was localized to the lower
incision and appeared 3 weeks after opera
tion. All infections cleared readily with
local treatment and none were followed by
prolonged drainage or incisional hernias.
The infections that complicated healing of
2 of the 10 dirty wounds occurred in wounds
that were closed primarily; we would now
use delayed primary closure for such inci
sions. Of the 27 wounds that were con
taminated or dirty 17 were treated by de
layed primary closure. This technique did
not seem to affect the healing of incisions
closed with Dexon, and prolonged drainage
did not occur.
Of the 93 patients in this series, 6 pa
tients died, from 5 days to 8 months after
operation. Some patients from out of town
were lost to follow-up, but 73% of surviv
ing patients were seen or contacted by tele
phone within 1 month of writing and all
surviving patients have been followed up
for at least 1 month. Although our study
was not a controlled one, our impression is
that Dexon gives much less long-term wound
discomfort than wire.
D iscussion
In spite of early pessimistic reports, Dexon
has proven successful for abdominal inci
sions.3’ 4 It loses strength more slowly
than catgut in experimental animalss and in
humans9 and loses less strength than catgut
on wetting and knotting.6 As others6 have
found, Dexon appeared to be stronger than
chromic catgut of the same calibre. Our
studies show that Dexon is excellent for
midline incisions, even in poor-risk patients.
The closure is secure even in the presence
of infection. We can make no claims for
prolonged security but no incisional hernias
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have developed up to 14 months after opera
tion.
The far-and-near (Smead-Jones) stitch
is superior to other methods of suturing, ■’
and external retention sutures are unneces
sary; however, wide placement of the su
tures in the fascia is important to give ade
quate holding power. We found healing ade
quate aftei; reclosure of old midline incisions
but the development of an incisional hernia
after closure of an old paramedian incision
with Dexon would make one more cautious.
It is likely that one could use continuous
Dexon for fascial closure, as we have done
successfully in a large number of dogs,
monkeys, baboons and pigs; but, although
some objections may be theoretical, we still
have reservations about such a closure. A
continuous suture technique is not as strong
as that using interrupted simple sutures,5
and neither technique is as strong as the farand-near technique we use.
The rate of wound infection in this study
was acceptable by current standards.10 The
clean wound infection rate of 1.8% is the
best judge of technique and our only case
of infection was late and localized. The rate
of infection in dirty wounds could have
been reduced even further by using delayed
primary closure in all such cases. This tech
nique is now standard for contaminated and
dirty cases in our centre and does not seem
to affect the holding power of Dexon.
Whether Dexon contributed to the low in
fection rate is not clear. Certainly this suture
produces little tissue reaction8 and less in
fection in contaminated tissue than catgut,11
also, Dexon does not lead to sinus forma
tion if wound infection does occur.
The advantages of Dexon over other su
tures for abdominal incisions are readily
stated. It offers more sustained holding
power and reliable absorption than chromic
catgut, with less tissue inflammation and
probably a lower contribution to infection.
Dexon seems to retain strength in the pres
ence of infection better than catgut, but it
does tend to cut through soft tissues more
than catgut. Dexon does not offer the sus
tained holding power of wire, though wire
sutures do break eventually, but it is easier
to handle and has less tendency to cut
through fascia. The incidence of incisional
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hernias with each is low, but Dexon seems
to give a more comfortable wound than
wire. A minor advantage of Dexon is the
ease of re-entry should a second operation
be necessary. Silk is slightly easier to han
dle than Dexon, but causes wound sinuses
and often late hernias if infection occurs.
Most other nonabsorbable braided sutures
have the same properties. Polypropylene
is an inert monofilament suture with sus
tained holding power that is satisfactory for
midline incisions, but it is difficult to handle,
requires multiple knots and may cause
wound sinuses, though much less often than
silk.12 Other absorbable sutures such as
polyglactin1'5 are being developed and these
may be satisfactory for abdominal closure
in the future. However, it would seem dif
ficult to improve on the midline incision
and Dexon closure that have given wound
security and comfort. The complete absence
of dehiscence, evisceration and incisional
hernia is proof of the effectiveness of the
suture.
In the present series, therefore, there were
no failures of technique associated with the
use of Dexon. In fact, we have noted only
one failure since we started using Dexon.
This occurred in a patient not included in this
study because she had a paramedian inci
sion. The initial incision was made else
where in a patient with perforation of the
cecum associated with a large bowel ob
struction caused by a carcinoma of the
splenic flexure. After a prolonged illness
resulting from sepsis, shock lung and renal
failure, left colectomy was carried out at our
centre. The patient was being treated by
hemodialysis at this time (serum creatinine
concentration, 12 mg/dl). Fascia and muscle
were closed in one layer with Dexon sutures.
There were no early wound complications,
but, 4 months later, an incisional hernia
was noted. It was not clear whether the
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hernia resulted from suture failure, poor
wound healing in a debilitated patient with
renal failure or inadequate bites of a pre
viously sutured paramedian incision. Eight
old midline incisions were closed from 1
week to 3 years after the initial procedure
without complication.
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SURVIVAL IN BREAST CANCER: STUDY OF 283 PATIENTS*
LUC DESCHENES, MD, FRCS[C] and JACQUELINE FABIA, MD, SD(Hyg)
Summary: Records of 283 women with breast
cancer diagnosed from 1965 through 1973 at
I’Hopital du Saint-Sacrement w ere studied for
survival at 3 and 5 years. These w ere all patients
who had not previously received cancer-directed
treatment. Life-table methods based on full in
tervals only were used to analyze survival.
Adjustment for deaths from other causes was
provided by computing the expected and relative
survival rates.
The 5-year relative survival rates (% ) were
60.2 ± 4.1 for the total group of 283 patients,
87.9 ± 4.5 for the 142 with localized disease and
44.9 ± 5.9 for the 118 with regional spread. Of
the patients with disease that was either local
ized or regional, 84% underwent total mastec
tomy. The age of patients at entry did not differ
from that of cases reported to the Quebec Tu
mour Registry. The significant increase over
tim e in the proportion of patients with localized
disease would be expected to reduce the
Quebec death rate from breast cancer in future
if the better survival of these patients is not
simply a function of earlier diagnosis.
Resume: La survie de 283 femmes atteintes de
cancer du sein diagnostique a I'Hopital du SaintSacrement de 1965 a 1973 a ete etudiee par la
methode actuarielle basee sur des intervalles
annuels complets. L'ajustement pour les deces par autres causes a ete obtenu en calculant
les taux de survie esperes et relatifs. Ces patientes sont toutes celles qui n'avaient pas anterieurement repu de traitement anticancereux.
Le taux de survie relatif (% ) a 5 ans est 60.2
± 4.1 pour le total des 283 patientes, 87.9 ±
4.5 pour les 142 patientes atteintes d’un cancer
localise et 44.9 ± 5.9 pour les 118 avec cancer
regional. Dans ces deux dernieres categories,
84% des patientes ont eu une mastectomie totale. L’age des malades a I'entree ne differe pas
de celui des cas declares au Registre des
Tumeurs du Quebec. L'accroissement significatif
de la proportion des cas localises entre 1965
et 1973 devrait reduire le taux de mortalite par

*From the department of surgery, H6pital du
Saint-Sacrement, and the department of social
and preventive medicine, Laval University,
Quebec, Que.
Presented in part at the meeting of the Canadian
Association of Clinical Surgeons, Quebec, Que.,
Mar. 14, 1975.
Reprint requests to: Dr. L. Deschenes, Department
of surgery, Hopital du Saint-Sacrement, 1050, Chemin Ste-Foy, Quebec, PQ. K1S 4L8.

cancer du sein au Quebec si la meilleure survie
de ces patientes n'est pas simplement fonction
d'un diagnostic plus precoce.

A lthough there have been a number of
reports of survival rates for women with
breast cancer, those from surgical depart
ments have usually focused on the compa
rison of results of treatment in specified
stages of the disease. The purpose of this
paper is to describe the overall survival of
283 women with breast cancer.
M ethods

Sources of Data and Period of Study

Records relating to all women in whom
breast cancer was first diagnosed from Jan.
15, 1965 through Sept. 1, 1973 at l’Hopital du Saint-Sacrement, Quebec City were
reviewed, as were records of the tumour
clinic supervising follow-up and records
of the department of histopathology. Death
certificates filed at the Quebec population
registry for patients reported to have died
were also reviewed.
Follow-up observations continued through
Aug. 31, 1974. All patients not known to
have died were contacted at the close of
the study. There were no losses to follow-up.

Criteria for Entry into Study

Entry into the study was restricted to pa
tients who had not previously received any
treatment for cancer, in accordance with the
criteria used by the End Results Group of
the US National Cancer Institute.1

Survival

Survival was measured from the date of
the first hospitalization during which breast
cancer was diagnosed.2 Life-table methods3
based on full intervals only4 were used to
analyze survival. To avoid biases linked
with incomplete intervals, patients due to
withdraw because of the end of the study
were removed at the start of the interval
and not during it, as recommended by
Drolette.4
Deaths from all causes were included in
the analysis in accordance with the state
ment of Paterson, Tod and Russell,3 cited
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TABLE I. __Survival * for 283 W omen

Year
a fte r
e n tr y

N o. of
p a tie n ts
a liv e at
s ta r t o f
in te r v a l

N o. of
p a tie n ts
w ith d r a w n
live a t sta r t
of
in te r v a l

283
249
191
127
%
68
*Rates computed by the
0
1
2
3
4
5

34
44
23
19

w ith

N o. of
p a tie n ts
under
o b se rv a tio n
d u r in g
in te rv a l
(0 )

N o. of
p a tie n ts
d y in g i n
in te r v a l

283
215
147
104
77

34
24
20
8
9

B reast C ancer (all S tages )

P ro b a b ility o f
d e a th i n
in te r v a l

(D)

(<? =

D/O)

0.120
0.112
0.136
0.077
0.117

P ro b a b ility
of
s u r v iv a l
(P = 1 - Q)

0.880
0.888
0.864
0.923
0.883

C u m u la tiv e
p r o b a b ility
o f s u r v iv a l
to s ta r t
of
in te r v a l

1
0.880
0.781
0.675
0.623
0.550

actuarial method and based on full intervals.

by Ederer, Axtell and Cutler6 that “no fig
ures which depend on opinion as to the
cause of death . . . can be accepted as com
pletely reliable”. The necessary adjustment
for mortality from causes other than breast
cancer and for association between age and
risk of death from other causes was provided
by computing the relative survival rate.7
The relative survival rate is defined as
the ratio of the observed survival rate
in a group of patients during a specified
period of time to the survival rate expected
over the same period in a group of persons
from the general population with the same
age and sex distribution as the patients.6 The
expected survival rates were computed with
the exact method6 from the 1970 to 1972
sex-specific life-tables8 for the population
of the Quebec City region; 88% of the
patients in this series came from this region.
The standard error of the observed sur
vival rate was computed from Greenwood’s
formula.6 The standard error of the relative
survival rate was obtained by dividing the
standard error of the observed survival rate
by the expected rate.6
Assessment of the Extent of Disease
Assessment of the extent of disease was
based on all information available at first
hospital discharge.1 Disease was classified
in three categories in conformity with the
classification adopted by the Connecticut
Cancer Registry16 and the US End Results
Program :11 localized (no evidence of spread
of tumour beyond the breast), regional
(evidence of spread to axillary or supra
clavicular lymph nodes, ipsilateral skin or
chest wall) and distant (evidence of metastases beyond the region).

R esults

Of the 283 patients included in the study,
142 were considered to have localized breast
cancer, 118 to have evidence of regional
spread and 23 to have distant metastases.
Among the patients with localized and re
gional disease, the diagnosis was confirmed
microscopically in 98.5% .
Survival for the 283 patients is sum
marized in Table I. The probability of death
was highest during the 3rd year after entry.
The trends of the observed and expected
cumulative survival rates are compared in
Fig. 1. The two curves are greatly divergent,
leading to a 5-year observed cumulative
survival rate of 55% and an expected sur
vival rate of 91.3%.
The 3- and 5-year relative survival rates
with their standard errors appear in Table
II together with the rates reported in the
most recent studies, in which the same cri
teria for admission of patients were used.^
The well-known highly significant difv.

Fig. 1.—Observed and expected survival rates,
1965 to 1973, all stages.
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TABLE II. R elative Survival R ates at 3 and 5 Y ears for B reast C ancer P atients (all Stages)
___________
Obtained in P resent Study and in F our R ecent Studies *
Relative survival rate,

Period of
entry

Study
Saint-Sacrement (Quebec) ...........................
US End Results Program.
.........................
Boston................
Glamorgan (Wales).......... ..........................
Tokyo...............

/

\

No. of patients

1965
1960
1965

—
—

1973
1964
1969

1965

—

1967

—

283
13 828
14 911
732
701
829

3-year
70.9
73
72
75.3
66.4
85.6

±

3.3

±

1.9
1.9
1.3

±
±

%

3-year
60.2
63
62 f

4.1

±

♦Sources: Morrison et al.2 and US Department of Health, Education and Welfare13
^ c t i o n based on the assumption that survival after 3 years is as good as that for patients diagnosed in

ference in survival between patients with
localized disease and those with evidence of
regional spread is illustrated in Fig. 2. The
5-year observed and relative survival rates
(%), adjusted to the age distribution of the
total group of patients, were respectively
82.1 ± 4.2 and 87.9 ± 4.5 for patients with
localized breast cancer versus 40.7 ± 5.2
and 44.9 ± 5.9 for those with regional di
sease (but these last two rates have rather
large standard errors and, therefore, are not
stable). For localized and regional cases

together, the 5-year observed and relative
survival rates were 59.7 ± 3.9 and 65 1 ±
4.2.
The proportion of all patients with local
ized disease increased significantly over
calendar time from 35.7% in the period
1965 through 1969 to 64.3% in the period
1970 through 1973 (Table III). This trend
started in 1968, the proportion rising stead
ily thereafter. Within each period, the pro
portion of patients with breast cancer that
was assessed as localized decreased with age
at entry.
The significantly lower median and mean
ages at entry for women with localized dis
ease is evident in Table IV. Also evident is
the finding that the median and mean ages
of patients at entry into our study were
not significantly different from those of
breast cancer cases reported to the Quebec
Tumour Registry from 1967 through

7.

1972.12

The distribution of treatment methods
among the 260 patients with localized or
regional disease is given in Table V. The
majority were treated by total mastectomy.
Only 28 (11% ) of patients underwent ra-

Fig. 2.—Relative survival rates, 1965 to 1973,
localized, regional and all stages.

TABLE III.—D istribution of B reast C ancer P atients According
and E xtent of D isease

to Age at E ntry, P eriod of

E ntry

Age at entry
<45
Period of entry

Extent of disease

n

1965 to 1 9 6 9 .

Localized
Regional
Distant
Total

16
15
2
33

Localized
Regional
Distant
Total

21
6
2
29

1970 to 1 9 7 3 .

. . .

..

%
48.5
45.4
6.1
100.0

72.4
20.7
6.9
100.0

45
n
14
21
1
36
25
10
3
38

—

54
%
38.9

55 -- 64
n
n

%
31.4

58.3
2.8
100.0

19
5
35

54.3
14.3
100.0

65.8

28
12
2
42

66.7

26.3
7.9
100.0

28.5
4.8
100.0

65 +
n
9
21
6
36
18
14
2
34

%
25.0
58.3
16.7
100.0

52.9
14.2
5.9
100.0

Total
n
50
76
14
140
92
42
9
143

%
35.7
54.3
10.0
100.0

64.3
29.4
6.3
100.0
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dical mastectomy; these were treated mostly
in the early part of the study period (1965
and 1966). Of the patients with evidence
of regional spread of the lesion, 91 under
went total mastectomy, 17 a radical mastec
tomy, 7 had nonsurgical treatment and 3
refused treatment. The disease in these 118
patients was considered to be regional be
cause of skin involvement in 14 instances
(11.9%), clinical involvement of axillary or
supraclavicular lymph nodes, or both, in 51
instances (43.2%), clinical and pathologic
involvement of lymph nodes in 30 instances
(25.4%) and pathologic involvement of
lymph nodes only in 23 instances (19.5%).
Cobalt was used alone in 2% of patients
and as an adjunct to surgical treatment in
85%. The total radiation dose used postoperatively on the axillary, supraclavicular
and internal mammary lymph node chains
was 5000 rads delivered over 5 weeks with
5 sessions per week of 200 rads at each
session.
D iscussion
The 3- and 5-year relative survival rates
(% ) for our patients (70.9 ± 3.3 and 60.2
± 4.1) are similar to those of the US End
Results Program for patients with all stages
of breast cancer diagnosed in 1960 to 1964
and 1965 to 1969 (72 and 62).13 In an in
ternational study conducted in the mid1960s, the 3-year relative survival rates
(% ) were 85.6 (Tokyo), 75.3 (Boston) and
66.4 (Glamorgan, Wales).2 According to
Morrison and colleagues,2 these significant
differences in survival are not explained by
the differences in extent of disease.
The rather low survival rate for the pa
tients with regional spread may possibly re
flect some degree of misclassification, for
two reasons. First, the McWhirter tech-

TABLE V.—D istribution
T reatment* for L ocalized

of
and

B reast C ancer
R egional C ases
N o . (a n d
% ) of p a tie n ts

T reatm en t

Total mastectomy. ..
+ radiation............
Alone.......................
Radical mastectomy.
+ radiation............
Alone.......................
Tumorectomy (with
or without radiation)........................
Radiation only..........
Other (medical).........
Refused.......................
Total...................

219

(84.2)

28

(10.8)

3
5
2
3
260

(1.2)
(1.9)
(0.7)
(1.2)
(100.0)

201
18
18
10

♦First course of treatment initiated within 6 mo of
entry.

nique,14 which was used in the majority of
the patients, does not lead to systematic exci
sion and pathologic examination of axillary
lymph nodes. This might results in classify
ing mainly cases with clinical involvement
of lymph nodes as regional. Second, modem
techniques for the detection of distant metastases were not available in the early years
of the present study, so that the disease in
some patients with distant metastases may
have been misclassified as regional.
Perhaps the most striking finding of this
study is the increase in recent years in the
proportion of patients diagnosed at the local
ized stage. If this trend applies throughout
the province of Quebec and if the better
survival observed for these patients is real
and not simply a function of earlier diag
nosis, the age-adjusted annual death rate
from breast cancer in Quebec should de
crease in the future.
We acknowledge the help of Drs. Paul Auger,
Robert Cote, Jean Couture and Claude Fortin of
the department of surgery, Jeanette La Vertu and
Pierrette Cote of the tumour clinic, and Michele
Beliveau of the medical records section, Hopital
du Saint-Sacrement; Dr. Jean-Marc Fredette of

TABLE IV —M edian and M ean Ages at E ntry for P atients in Study According to E xtent of
D isease and for Breast C ancer P atients R eported to Quebec T umour R egistry (1967 to 1972)
F em ale p a tie n ts reported to
Quebec T u m o u r R e g istry
{1 9 6 7 to 1972)

P a tie n ts in stu d y
L ocalized
(n — 142)

Regional
(n = 118)

53.5
Median age (yr). . . .
54.0
Mean age (yr).........
12.5
Standard deviation..
♦This total does not include 170 cases

57.2
58.1
13.7

D ista n t
(n = 23)

59.4
57.3
14.1

of unknown age.

A ll stages
{N = 283)

55.7
56.0
13.3

A l l stages
( N = 9959*)

55.9
56.8
13.2
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the Quebec Population Registry, Ministry of So
cial Affairs; and Widna Morin, department of so
cial and preventive medicine, Laval University.
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CUTANEOUS GANGRENE: A RARE COMPLICATION OF
COUMARIN THERAPY*
M. SHNIDER, MD and C. R. D’SOUZA, MD, FRCS[C]
Summary: Sodium warfarin was administered to
a 59-year-old woman with congestive cardiac
failure and deep vein thrombosis. After 3 days
of therapy the nipple and areola of the left
breast became inflamed; the entire breast then
became necrotic. Gangrene spread and a simple
mastectomy was performed. The patient died
from pulmonary embolism 1 day after operation.
Histologic examination of the breast revealed
thrombi in some of the arteries and veins. The
etiology of this condition is obscure, and there
is no known way of preventing or effectively
treating the condition. Simple mastectomy or
more conservative local excision recommended.
Resume: A une femme de 59 ans souffrant d’une
insuffisance cardiaque et d'une thrombose veineuse profonde, nous avons administre de la
warfarine sodique. Trois jours apres le debut
de ce traitem ent, le mamelon et I’areole du
sein gauche devinrent enflammes, puis le sein
devint completement necrose. La gangrene s'etant repandue, nous avons pratique une mastectomie simple. La patiente est decedee le lendemain de I'operation d'une embolie pulmonaire.
L'examen histologique du sein a revele des

*From the department of surgery, Flin Flon
General Hospital, Flin Flon, Man.
Reprint requests to: Dr. M. Shnider, Depart
ment of surgery, Flin Flon General Hospital, Flin
Flon, MB R8A 1N2.

thrombi dans certaines veines et arteres. L'etiologie de cette pathologie demeure obscure et
on ne connait aucun moyen de la prevenir ou
de la traiter efficacement. Une mastectomie
simple ou une excision locale plus conservatrice
est le traitement que nous recommandons.

T h e common complication of coumarin
derivatives such as bishydroxycoumarin (dicumarol) is bleeding, but a rare complica
tion is cutaneous gangrene. Its occurrence
is unpredictable and unrelated to dose, and
its course is influenced neither by stopping
nor continuing administration of the drug.
Few cases of the condition have been re
ported.1 The following is one such case.
C ase R epo rt
A 59-year-old woman was admitted with
sudden onset of dyspnea, constrictive retro
sternal pain and edema of the feet. A diagnosis
of congestive cardiac failure was made and
digoxin and diuretics were given. Left calf
tenderness and a positive Homan’s sign 10 days
later led to the diagnosis of deep vein throm
bosis of the left leg.
Treatment with sodium warfarin (Coumadin)
was started and prothrombin times were meas
ured daily (Table I). After 3 days of therapy
the nipple and areola of the left breast ap-
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peared red and inflamed and a blister developed. Sodium warfarin was stopped on the 3rd
.
day. The lesion became tender and then ne
crotic over an area of 5 cm. The entire breast
y
was inflamed and swollen to about twice its
normal size. The necrotic tissue was excised
3 days later under local anesthesia. The ne
crotic area extended through the breast and
down along the pectoral fascia. Cultures of the
tissue did not grow any organisms. Treatment
with hydrocortisone (Solucortef) by intramus•v
cular injection was started (100 mg lid) and
continued for 1 week. The gangrene gradually
spread’ and, in spite of her poor general condi
tion, it was decided 10 days later to do a
simple mastectomy. She died on the day after
'j
operation from a massive pulmonary embolism.
Histologic examination of the breast revealed
the following findings: The skin showed ex
tensive changes; many of the small vascular
'
spaces (venules) contained thrombi, as did
some of the larger arteries and veins, a few
vessels (mainly arteries) manifesting an acute
- *• inflammatory reaction; scattered through the
*
debris was a prominent cellular infiltration of
l
polymorphs and numerous eosinophils; some
adnexal glands showed partial ischemic necrosis.

D iscussion

»a
y

*

^
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Bishydroxycoumarin and congeners, used
therapeutically to produce hypoprothrombinemia, depress the vitamin K-dependent
clotting mechanism through their effect on
Factors II, VII, IX and X. The Quick onestage prothrombin time is prolonged; it is
maintained at a therapeutic level of 2.5 to 3
times the normal.
The adverse effects of these drugs are
threefold: (a) hemorrhage of minor or ma
jor extent from any tissue or organ; (b) sys
temic reactions such as fever, nausea, diar
rhea and alopecia; and (c) skin reactions.
The skin reactions include ecchymosis and
purpura due to hypoprothrombinemia;
masculopapular, vesicular and urticarial
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eruptions; the “purple-toes” syndrome;2 and
the rare necrosis—usually of the breasts,
thighs and flanks.
Few cases of skin necrosis associated
with use of coumarin derivatives have been
reported in the English literature. Although
Flood and associates3 in 1943 first de
scribed a case of breast gangrene in a pa
tient receiving bishydroxycoumarin they in
terpreted the changes as being manifesta
tions of thrombophlebitis migrans disse
minata from which the patient suffered.
Kipen4 in 1961 was the first to associate
breast changes with sodium warfarin ther
apy. By 1971 at least 150 cases of cuta
neous necrosis had been reported, in 25 of
which the breast was affected.5
Both bishydroxycoumarin and sodium
warfarin have been implicated. Heparin
alone has not produced this complication
although it has been used frequently to in
itiate anticoagulation.6
The condition usually affects middle-aged
or elderly women.7 It begins between the
3rd and 10th day of treatment; in 93% of
cases it begins between the 3rd and 5th
day.1 It is unaffected by discontinuance of
coumarin congeners and, once therapy has
been started, it progresses inexorably. Con
tinuation of therapy after skin lesions have
developed does not result in untoward re
actions, new skin lesions, exacerbation of
existing lesions, or impairment of healing.8
As the present case indicates, there is no
correlation between the prothrombin value
and the appearance of the skin lesions9 (Ta
ble I).
Clinically, the disorder affecting the
breast is characterized by pain, redness, in
duration and formation of bullae that con
tain serosanguinous fluid. A well-demarcated
eschar soon forms. Biopsy of the lesion at

TABLE I.—D ose of Sodium W arfarin, P roi rombin T ime and O nset of C linical F eatures
Preoperative
Prothrombin time
Sodium warfarin doseclinical course
(% of normal)
{mg)
Day of treatment
—
—
10
1
—
32
5
2
—
15
Q
10
Erythema and blister, left nipple
40
4
Nil
Erythema and blister
30
R
Nil
Erythema and blister
26
a
Nil
Erythema and blister
40
7
Nil
Frank gangrene
45
g
Nil
Excision
40
Nil
9

The Effect of

Trasy
lol
in

* Results

Acute
Pancreatitis
G r o u p A (T ra s y lo l)

G r o u p B (P la c e b o )

C o u r s e o f illn e s s

No.

%

No.

%

M ild
M o d e ra te
S e v e re
D ie d

30
13
6
4

5 6 .6
2 4 .5
1 1 .3
7 .5

22
9
8
13

42 3
17 3
15 4
2 5 .0

T o ta l

53

9 9 .9

52

1 0 0 .0

e x te n t^ W3S shown to reduce mortality in acute pancreatitis to a significant
Placeb0................................................ 25.0% Mortality
Trasylol®...............................................
7.5% Mortality
“ Because the number of deaths were reduced, the spectrum of the disease
as a whole was altered.” *
Trapnell’s recent double-blind clinical trial
involving 105 patients confirmed the
effectiveness of Trasylol in acute
pancreatitis. In addition to reducing
mortality and altering the spectrum of the
disease, Trasylol largely abolished the usual
effect of increasing age in this condition.
Trasylol should be given concurrently with
usual measures for the treatment of
pancreatitis, such as pain relief,
fasting, gastric suction, etc. “ It
(Trasylol) can therefore now be
regarded as a drug which is both
effective and beneficial in the
treatment of acute pancreatitis.” *
*Trapnell, J.E. et al, British
J. Surg., March 1974.

The Effect of

Trasylol
in
Hyperfibrinolytic
Hemorrhages

A

Trasylol, in its role as an
antifibrinolytic agent, inhibits
both plasmin and the
plasminogen activator.

Synthetic antifibrinolytic
agents inhibit only the
plasminogen activator,

Trasylol is indicated for primary and generalized, secondary
hyperfibrinolytic hemorrhages with and without the shock
syndrome. Secondary hyperfibrinolysis following
intravascular clotting may require heparin and/or
fibrinogen replacement in addition to Trasylol.
With Trasylol, the antifibrinolytic agent with
simultaneous anti-coagulant (anti-thromboplastic)
effect, there will not be a dangerous shift
in the equilibrium between
the clotting and the lysis system
in favour of coagulation.
Synthetic antifibrinolytics
are contraindicated if there is
evidence of active intravascular
coagulation. Trasylol is indicated
in all cases of hyperfibrinolysis,
whether a differential diagnosis
has been made or not.
FBA Pharmaceuticals Ltd.
Distributed by:
Boehringer Ingelheim (Canada) Ltd.
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Trasylol
• increases the chances
of survival in acute
pancreatitis
• prevents the enzymatic
release of toxic
polypeptides and kinins
• stops hyperfibrinolytic
hemorrhage
Indications and Dosage

Hyperfibrinolytic Hemorrhage
T h e se c o n d itio n s o c c u r in s u rg e ry ,
including open heart surgery, p rostatic
s u rg e ry and p a th o lo g ica l o b s te tric a l
bleeding conditions, such as in abruptio
placentae.
Initial dosage: 200,000 — 500,000 K.I.U.
of w hich 200,000 K.I.U. should be given
by intravenous injection (a t a rate not to
exceed 5 ml per minute), the rest if neces
sary by slow infusion. A d m in is tra tio n
sh o u ld be co n tin u e d up to 1,000,000
K.I.U. per day until the hemorrhage has
been arrested.

Pancreatitis
Initial dosage: 100,000 — 200,000 K.I.U.
to be follow ed by 100,000 K.I.U. every
six hours fo r a period of 4-5 days. The
drug is adm inistered e ith e r by intraven
ous in je ctio n (at a rate not to exceed 5
ml per minute) or by slow infusion.
Warnings and Precautions
Trasylol is a polypeptide and thus may
act as an antigen. Although adverse reac
tions due to hypersensitivity have been
described infrequently, this possibility
should always be kept in mind. In patients
w ith a h is to ry of h yp e rs e n s itiv ity , th e
usual precautions for the prevention and
a rre s t o f a lle rg ic re a c tio n s sh o u ld be
observed p rio r to the adm inistration of
Trasylol.
Availability
Trasylol (aprotinin) is available in 10 ml
a m p u ls c o n ta in in g 1 0 0 ,0 0 0 K .I.U . in
boxes of 5 ampuls.
Trasylol® Product Monograph is available
on request.

The object of

Trasylol:
Control of proteolytic enzymes.
FBA Pharmaceuticals Ltd. (

)

Distributed by:
v z fy
Boehringer Ingelheim (Canada) Ltd.
2121 Trans Canada Highway, Dorval, P.Q. H9P1J3
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this time reveals necrotizing arteritis, venous
thrombosis and severe necrosis; these
changes differentiate the condition from sim
ple hemorrhage in tissues. Extramammary
lesions tend to affect thighs and gluteal re
gion; face, hands and feet are seldom in
volved. 10 The etiology of the condition is
obscure. Allergic reaction, hypersensitivity
and toxic reactions have been proposed as
the mechanisms of injury.11- 12
No way is known of predicting, prevent
ing or effectively treating the condition.
Steroids, heparin, 13 local hypothermia, and
sympathetic nerve blocks are equally inef
fective. Simple mastectomy or more con
servative local excision5 is recommended.
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INCREASING OPERABILITY AND SURVIVAL WITH INTRA-AORTIC
BALLOON PUMP ASSIST*
B S GOLDMAN MD, FRCS[C], FACS,t J. GUNSTENSEN, MD, FRCS[C],{
B- SB W GILBERT MD,§ T. C. KELLY,If H .SCULLY^M D FRCSJGLJI
W. G. WILLIAMS, MD, FRCS[C] and A. G. ADELMAN, MD, FRCP[C]
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Summary: Intra-aortic balloon pump assist
(IABPA) was used over a 12-month period in the
management of 41 patients: 5 patients with
complications of myocardial infarction in shock
whose circulation was supported by IABPA be
fore operation immediately after angiogra
phic and hemodynamic study (group 1): 14
patients with postcardiotomy low-output state
who could not be weaned from cardiopulmonary
bypass and required IABPA circulatory support
either in the operating room or in the intensive
care area (group 2); 19 patients with severe
myocardial ischemia and unstable circulation in
whom IABPA was instituted either before angio
graphy or before saphenous vein bypass oper
ation (group 3); and 3 patients with severe left
ventricular dysfunction and left ventricular hy
pertrophy due to aortic valve or coronary artery
disease, or both, in whom IABPA was used
before, during and after cardiopulmonary bypass
and a corrective operative procedure (group 4).
Survival rates for patients in these groups were
2/5, 8/14, 18/19 and 2/3 respectively (overall sur
vival, 73%). IABPA may increase the post
operative survival of certain high-risk patients
with poor left ventricular function due to val
vular disease or coronary artery disease, or
both. The survival of patients with severe myo
cardial ischemia and complicated myocardial in
farction is improved by IABPA, early angiography

*From the divisions of cardiovascular surgery and
cardiology, Toronto General Hospital, Toronto,
Ont.
Presented at the 46th annual session of the Amer
ican Heart Association, Dallas, TX, November
1974.
Supported in part by the Ontario Heart Founda
tion and the Theodore Richmond Cardiovascular
Fund.
f Assistant professor, department of surgery,
University of Toronto.
{Clinical fellow, division of cardiovascular sur
gery, Toronto General Hospital.
§Clinical fellow, division of cardiology, Toronto
General Hospital.
^Biomedical technician, Toronto General Hospital.
|| Lecturer, department of surgery, University of
Toronto.
**Assistant professor, department of medicine,
University of Toronto.
leprint requests to: Dr. B. S. Goldman, Cardioascular unit, Toronto General Hospital, 101
College St., Toronto, ON M5G 1L7.

and appropriate surgical correction. Left ventri
cular ejection fraction and the estimate of
subendocardial coronary flow by the ratio of the
diastolic pressure time index to the tension time
index appear to be significant in identifying pa
tients who may benefit from the use of IABPA.
Resume: Le bailon-pompe intra-aortique (BPIA) a
ete utilise pendant une periode de 12 mois pour
traiter 41 patients: le groupe 1 compose de 5
malades souffrant de complications d'un infarctus du myocarde et en etat de choc; le BPIA
a aide la circulation avant I’operation et immediatement apres angiographe et etude de I'hemodynamique (un des malades, inoperable, est
decede). Le groupe comprenait 14 malades qui,
apres cardiotomie, presentaient un faible debit
cardiaque et qui ne pouvaient se passer de la
derivation cardiopulmonaire; on a done utilise le
soutien circulatoire fourni par le BPIA, soit dans
la salle d'operation, soit dans I'unite des soins
intensifs. Le groupe 3 etait compose de 19 ma
lades, souffrant d'une severe ischemie du myo
carde, et d’une circulation instable; chez ces ma
lades, on a eu recours au BPIA soit avant I'angiographie, soit avant I'operation de pontage de la
veine saphene. Quant au groupe 4, il comprenait
trois malades souffrant d'un severe dysfonction
nement du ventricule gauche et d'une hypertrophie dudit ventricule, attribuable a une valvulopathie aortique ou a une insuffisance coronarienne (ou aux deux pathologies) et chez lesquels
on a utilise le BPIA avant, pendant et apres la
derivation cardiopulmonaire et I'operation correctrice. Chez les malades de ces groupes, le
taux de survie a ete de 2/5, 8/14, 18/19 et 2/3
respectivement (survie globale de 73% ). Le BPIA
permet d'augmenter la survie postoperatoire de
certains malades dont le risque est particulierement eleve et dont la fonction du ventricule
gauche est mediocre, par valvulopathie ou par
une deficience coronarienne ou par les deux. Le
BPIA peut ameliorer la survie de malades souf
frant d’une severe ischemie du myocarde et d'un
infarctus du myocarde complique, cet appareil
facilitant une angiographie precoce et la correc
tion chirurgicale appropriee. Le rapport de la
pulsion du ventricule gauche a la pulsion diastolique est un indice precieux qui permet d’evaluer dans quelle mesure la circulation corona
rienne est amelioree et, par consequent de reconnaitre les personnes qui sont susceptibles
de beneficier du bailon-pompe intra-aortique.
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Abbreviations
AMI
ACB
AVR
Cl
D PT I/T T I
EF
IABPA
LVF
MVR
OR
RR
TGV
VF

Acute myocardial infarction
Aortocoronary bypass
Aortic valve replacement
Cardiac index
Diastolic pressure time index
/tension time index
Ejection fraction
Intra-aortic balloon pump
assist
Left ventricular function
Mitral valve replacement
Operating room
Recovery room
Transposition of great vessels
Ventricular fibrillation

I ntra-aortic balloon pump assist (IABPA)
has been moderately successful in the man
agement of cardiogenic shock due to acute
myocardial infarction (AM I).1' 2 Temporary
improvement and stability of the altered
hemodynamic state permits diagnostic evalu
ation and surgical therapy when appropri
ate.2- 4 IABPA is also useful in providing
circulatory assistance in patients with the
low-output state that may follow cardiac
surgery.:> It is being used increasingly in the
management of refractory or recurrent myo
cardial ischemia with relief of ischemic
pain,0 and angiographic and hemodynamic
investigative procedures and myocardial re
vascularization can then be accomplished.7
The physiologic benefits of balloon pump
counterpulsation stem from decreased left
ventricular afterload and thus decreased
systolic work with a consequent decrease in
myocardial oxygen demand.8 Diastolic aug
mentation increases aortic root pressure with
a potential increase in coronary flow.9 In
this paper we review our experience with
intra-aortic balloon pumping using the
AVCO console*.
*Kontron Scientific Ltd., Montreal, Que.
TABLE I.—U se

of

Complicated myocardial infarction........................
Postcardiotomy low output....................................
Severe coronary insufficiency.................................
Preoperative circulatory support...........................
T otal...............................................................

and

M ethods

Details of Patient Groups
In the 12-month period from Oct. 1,
1973 to Oct. 1, 1974, 44 patients were con
sidered candidates for IABPA. IABPA was
used in 41, in four groups (Table I): in
5 who had life-threatening complications of
extensive AMI (group 1); in 14 patients
who could not be weaned from cardiopul
monary bypass or who had low-output states
in the recovery room after cardiovascular
surgery (group 2); and in 22 patients with
severe coronary artery insufficiency (19
with coronary artery disease [group 3] and
3 with combined aortic valve and coronary
artery disease [group 4]), prophylactically,
for circulatory support just before operation,
support being continued during operation
and the postoperative period. In three other
patients, who subsequently died, the balloon
catheter could not be inserted because of
extensive atherosclerosis in the iliac arteries
and abdominal aorta; one had cardiogenic
shock, a second had severe coronary artery
insufficiency and the third had a low-output
state postoperatively.
Group 1.— Myocardial infarction in all
five patients was documented by serial elec
trocardiographic and enzyme changes. In
four, cardiogenic shock developed 12 to 24
hours after infarction, as evidenced by ar
terial systolic pressures below 80 mm Hg,
a urine output of less than 20 m l/h, vary
ing degrees of mental obtundation and peri
pheral vasoconstriction (Table II). Although
all four received medical therapy to correct
hypoxia, acidosis or hypovolemia as well as
inotropic and vasopressor agents when in
dicated, their clinical condition was deterior
ating when IABPA was instituted. Heart
catheterization was then carried out and
three of these four patients subsequently
underwent operation. In the fifth patient of
this group recurrent attacks of ventricular
tachycardia had continued despite intensive

I ntra-aortic B alloon P ump A ssist According

Group no. and diagnostic category

1
2
3
4

P atients

Vol. 19

to

P atient G roup,

No. of patients

5
14
19
3
41

and

Survival

No. of patients surviving

2
8
18
2
30 (73%)
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TA BLE I I.—D etails of P atients in G roup 1 (M yocardial I nfarction w ith C omplications)

Patient
no. Age, sex
1

47. M

2

45, M
38, M

3

61, M
56, M

4
5

t-

^

v
t
-1

't
*
^-y
,

Previous
infarction
No

LVF,
grade
I-IV

Complication
Ventricular aneurysm, shock

9, 7 yr Shock
earlier
Shock
2 yr
No
2 mo

M itral regurgitation, shock
Ventricular aneurysm,
recurrent VF

EF,
%

1:1 assist
Coronary score
duration,
LVEDP,
Result
min
Operation
Poslop.
Preop.
D
P
T
I/T
T
I
mm Hg
Died
192
7 Aneurys
7
0.56
16

IV

9

III

41

25

1.07

11

IV

7

43

0.50

IV
III

0.56
1.03

16
22

9
9

antiarrhythmic therapy and the balloon was
inserted after angiography had visualized a
resectable aneurysm.
Group 2 .— Of the 14 patients, 11 had
undergone aortocoronary bypass (ACB), 2
had received aortic valve replacement (AVR)
and 1 had undergone corrective surgery for
transposition of the great vessels (TGV)
(Table III). Nine of them could not be
weaned from cardiopulmonary bypass and
the balloon was inserted before bypass
was discontinued; in the other five the
balloon was inserted because a low-output
state persisted after operation. Low output
in these five patients was characterized by a
systolic pressure below 80 mm Hg, urine
output of less than 20 m l/h and varying
degrees of peripheral vasoconstriction in
spite of blood volume adjustment, assisted
ventilation and pharmacologic therapy.
Group 3 .— All 19 patients had unstable
angina or severe coronary artery insufficiency
(Table IV). Of the 19, 10 were considered
to have preinfarction angina in that they had
severe prolonged episodes of chest pain with
ischemic electrocardiographic changes at
rest. This pain was unrelieved by nitrites or
propranolol and lasted longer than 20 minutes. The other nine patients were regarded
as having crescendo angina because of re
current attacks of angina at rest occurring
with increasing frequency and severity to
gether with ischemic electrocardiographic
changes at rest. In these 9 patients, in con
trast to the 10 with preinfarction angina,

mectomy
ACB

70

10

Inoperable

144

8
11

MVR
Aneurys
mectomy

36
70

8

8
8

Alive
Balloon-dependent,
died
Died
Alive

the pain of crescendo angina was relieved
by nitrites. All 19 patients were monitored
in the coronary unit, where serial electro
cardiograms and enzyme studies showed no
evidence of infarction. In 2 of the 19 pa
tients the balloon was inserted before heart
catheterization, and in the other 17 it was
introduced before ACB.
Group 4.— The three patients had long
standing aortic valve and coronary artery
disease and were severely disabled with an
gina and left heart failure (Table V). IABPA
was instituted before operation for prophy
lactic purposes.
Investigative Procedures
The patients in all four groups underwent
right and retrograde left heart catheterization
by the standard Seldinger technique. The
cardiac output was measured by the Fick
method. The pressures were recorded with
Statham P23 transducers. Left ventricular
angiograms were performed in the 30-de
gree right anterior oblique projection by in
jecting Renografin 76% (dose, 40 to 50 ml)
into the left ventricle. Selective coronary
cineangiograms were obtained by the Jud
kins technique. The end-diastolic and endsystolic silhouettes were outlined from the
cineangiograms and presented to a television/computer system for calculation of ven
tricular volumes and ejection fractions (EF)
by means of Simpson’s rule.10 Left ventri
cular function (LVF) was also assessed sub
jectively by two observers; it was graded I

TA BLE I I I —D etails of P atients in G roup 2 (P ostcardiotomy L ow Output)

Coronary score
Age, sex

6
7
8

9

10
11
12

13

14

15
16
17
18
19

50, M
60, F
58, M
45, M
58, F
50, F
57, M
63, M
61, M
64, M
35, M
55, M
33, M
20, M

NA — not assessed.

LVF grade,
I-IV
II
II
III
II
II
II

III

III
II

I

II
NA
NA

EF,
58
55
36
85
51
67
62
42
21
53
73
53
NA
NA

LVEDP,
Cl
l/m inm m 2 mm Hg
NA
2.61
2.91
3.53
2.41
3.85
NA
2.25
1.89
1.37
4.61
1.71
1.54
NA

11
5

8

18
17
8

16
9
17
5

6

55
33

20

D P T I/T T I Preop.
1.15
0.62
0.54
0.76
0.37
0.63
0.67
0.54
0.65
1.80
0.93
0.83
0.78
NA

7
15
9
10
9
9
12
11
17
13
9

1

NA
NA

Postop.
2
10

0
4
5

6

10
3
12
5
2
1

NA
NA

Operation
2 ACB
1 ACB
2 ACB
2 ACB
1 ACB
1 ACB
2 ACB
2 ACB
1 ACB
2 ACB
2 ACB
AVR
AVR, MVR
TGV

Initiation

min

OR
OR
OR
OR
OR
OR
OR
RR
RR
RR
RR
OR
RR
OR

47
24
31
36
72
36
12
53
54
0.5
1
48
2.5
0.5

Results
Alive
Alive
Alive
Alive
A M I,
AM I,
A M I,
Alive
Alive
A M I,
A M I,
Alive
Died
Died

alive
died
died
died
died
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TABLE IV.

Patient
no. Age, sex

D etails

of

LVF,
grade EF,
I-IV
%

P atients

in

Vol. 19

G roup 3 (Severe C oronary Artery I nsufficiency )

Cl
Coronary score
l/min- L V E D P ,
mm2 mm Hg D P T I / T T I Preop. Postop.

1:1 assist
duration,
min

Results

Preinfarction angina
20
21
22
23
24
25
26
27
28
29

55, M
42, F
45, M
53, M
50, M
50, M
58, M
63, M
53, M
56, F

IV
III
II
III
III
II
I
III
II
III

13
13
68
39
51
79
73
48
77
24

NA
1.10
NA
3.55
NA
3.35
4.30
NA
4.22
1.69

14
14
13
8
29
7
12
11
11
17

1.28
0.92
0.70
1.07
0.66
0.30
0.68
0.45
0.55
1.00

8
8
6
20
10
11
14
13
10
8

1
0
2
0
1
8
0
4
0
0

24
92
4
52
44
36
61
11
168
2

AML died

9
15
7
11
11
12
9
11
12

5
3
3
7
9
8
5
5
3

96
25
18
37
70
18
48
27
45

Alive

AMI, alive
AMI, alive

Crescendo angina
30
31
32
33
34
35
36
37
38

58, M
41, M
63, M
57, M
53, M
55, F
53, F
57, M
54, M

III
III
IV
IV
III
III
IV
III
IV

40
34
17
29
40
36
36
49
8

3.84
2.70
2.19
4.30
3.02
2.70
1.40
3.79
1.83

20
25
24
11
11
10
5
6
30

0.54
1.00
0.79
1.05
1.02
0.83
0.44
0.41
0.80

NA — not assessed.

to IV— grade I being normal, grade II mild
ly decreased, grade III moderately decreased
and grade IV, severely decreased left ven
tricular contraction. Coronary artery scores
were calculated using a slightly modified
Friesinger technique.11 Complete occlusion
was graded V, narrowing of 90 to 99% was
graded IV, multiple lesions with narrowing
of 50 to 90% were graded III, narrowing
of 50 to 70% was graded II and irregular
ities with up to 50% narrowing were graded
I. Double value was given for lesions in the
left main system. Finally, the subendocar
dial blood supply/demand relationship was
estimated by Buckberg’s formula by calcul
ating the ratio of the diastolic pressure time
index to the tension time index (D PTI/
TTI).12 This is derived from planimetry of
the areas under the left ventricular and
aortic pressure tracings. In all 41 patients the
intra-aortic balloon was inserted through
the common femoral artery using techniques
previously described.3 Balloon inflation and
deflation was triggered from surface elec
trocardiograms and was adjusted to produce
maximum reduction in aortic systolic pres
sure with maximum diastolic augmentation.
During cardiopulmonary bypass the bal
loon catheter was inflated and deflated by
means of an external artificial pacemaker.

This converted the mean flow of cardiopul
monary bypass to a phasic pattern. The
degree of pulsatile flow could be altered by
Changes in the balloon volume (Fig. 1).
Whenever technically possible, saphenous
vein bypass graft flow was measured by an
electromagnetic flowmeter both on and off
intra-aortic balloon counterpulsation.
R e su lt s

Group 1
All five patients had elevated end-dia
stolic pressures, decreased ejection fractions
and severe left ventricular dysfunction.
Results are summarized in Table II. Patient
3, whose condition was considered inoper
able, was dependent on the balloon and died
150-1

5010ml

20 ml

0J

F'g- 1.—Pulsatile systemic flow obtained during
extracorporeal perfusion with simultaneous IABPA
and different balloon volumes. Alterations in bal
loon volume (10, 0 and 20 ml) alter degree of
pulsatile flow. Balloon is triggered by square
wave impulse from artificial external pacemaker.
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• SURVIVORS

on the 8th day, after inadvertent kinking
and rupture of the balloon catheter at the
groin during a period of restlessness. Pa
tients 1 and 4 died after operation, one
from an intractable cardiac arrhythmia and
one from a noncardiac complication (tra
cheal necrosis) after successful weaning from
balloon support.

Group 2
Of the 14 patients 8 survived (Table III).
It was not always possible to determine why
the patient could not be weaned from car
diopulmonary bypass or a low-output state
after cardiac repair. In most instances, this
was presumed to be due to myocardial in
jury from prolonged anoxic arrest, inade
quate revascularization or intraoperative
infarction. Survival was slightly higher when
IABPA was used in weaning from cardio
pulmonary bypass than when its application
was delayed (Table III). Of the nine pa
tients in whom the balloon was inserted
in the operating room (OR) at the end of
cardiopulmonary bypass six survived, com
pared with two of five patients in whom bal
loon support was instituted in the recovery
room (RR) after an attempt to correct the
low-output state by traditional means. Five
patients sustained myocardial infarction perioperatively before IABPA was initiated
and four of these patients died.
Of the 14 patients in this group 11 had
undergone operation for coronary artery
disease with stable angina and were not con
sidered to be at increased risk. In seven of
them D PTI/TTI ratios were less than 0.7,
and in two, EFs were less than 40% . In a
random group of 16 patients with stable an
gina who underwent uneventful saphenous
vein bypass surgery D PT I/T T I ratios ex
ceeded 0.7 and the left ventricular EFs
were greater than 40% (Fig. 2a).
Group 3
Among the 19 patients the EF was 40%
or less in 12 and D P T I/T T I ratios of
0.7 or less were demonstrated in 9 (Table
IV) (Fig. 2b). In two patients there were
low EFs and low D PT I/T T I ratios. In
patient 29, in whom general anesthesia was
induced before the balloon was inserted, the
blood pressure decreased precipitously be
fore balloon pumping could be commenced.

• SURVIVORS
o DEATH

10
so

lzt

60

40
20

-

i

0.2

0.4

_J_______I—

____ 1__

0.6 0.7 0.8

1.0

1.2

1.4

DPTI/TTI

Fig. 2b
Fig. 2.—Plots o f left ventricular EF versus
D PT I/T T I ratio (solid circles, survival; open
circles, death), (a) Random group of 16 patients
with stable angina who underwent saphenous vein
bypass; all had evidence o f good left ventricular
function and subendocardial flow and none re
quired IABPA. (b) Group o f 19 patients with un
stable angina who underwent IABPA and m yo
cardial revascularization; illustrates that most had
either poor ventricular function or impaired sub
endocardial blood flow.

Although resuscitation was effected and
ACB to the anterior descending coronary
artery was performed, it was not possible to
wean this patient despite IABPA.

Group 4
All three patients had aortic valve steno
sis, concomitant coronary artery disease,
left ventricular dysfunction and low D P T I/
TTI indices (Table V). These patients were
considered extremely high risks and in fact
two of them had previously been denied
surgery. Patients 39 and 40 underwent AVR
alone. Patient 41 underwent AVR and
double saphenous vein bypass grafting
but died from severe aortic regurgitation,
a calcific annular plaque preventing the
ball of the prosthesis from seating. With
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diastolic augmentation in progress the result
ant aortic regurgitation proved fatal.
Other Complications

In the entire series of 41 patients there
were only two other complications related
to the use of the balloon. One was mild
claudication that developed in the limb used
for insertion of the balloon in a patient
who had been successfully treated for car
diogenic shock after myocardial infarction.
The other complication was the kinking of
the balloon catheter in patient 3.
Saphenous Vein Bypass Blood Flow

In those patients in whom measurement
was possible, a distinct increase in blood
flow in the saphenous vein/coronary artery
bypass was inevitably noted.
D iscussion

Intra-aortic balloon pumping produces
a favourable hemodynamic response for
patients in cardiogenic shock resulting from
AMI and by itself leads to a modest in
crease in survival.1' 2 Further improvement
in survival may be achieved by vigorous sur
gical therapy after hemodynamic stabil
ization and angiographic study.3- 4 Post
operative cardiogenic shock may be related
to inadequate surgical repair, surgical mis
adventure or prolonged anoxic arrest.
IABPA has been successful in this situation,
particularly when applied early, for wean
ing from cardiopulmonary bypass in the
operating room.13
The management of acute, severe coro
nary artery insufficiency has developed ap
preciably since the introduction of the
saphenous vein bypass operation. However,
despite early reports from randomized trials,
there is at present no clear indication that
medical or surgical therapy is unequivocally
superior in terms of prevention of myocar
dial necrosis or ultimate survival.14- 15
Gazes and his colleagues16 have suggested
that there is a high mortality for a specific
subgroup of patients with “preinfarction

states”, but the literature gives no clear de
finition of comparable patient groups.
None the less there is an obvious trend
to early investigation and early myocardial
revascularization for patients with severe
coronary artery insufficiency.17- 18 The
degree of left ventricular dysfunction rather
than the severity of myocardial ischemia
may be the limiting factor in survival from
coronary artery surgery. Despite successful
revascularization it is acknowledged that the
long-term result in these patients is un
known.
In an early review of experience with
unstable angina, our group found a mortal
ity rate of zero for patients with crescendo
angina and adequate left ventricular func
tion undergoing saphenous vein bypass
operation; however, 12 of 16 patients oper
ated on after prolonged medical therapy
for recurrent acute coronary insufficiency
(preinfarction angina) died, and histopathol
ogic evidence of subendocardial necrosis
was correlated with low preoperative D PT I/
TTI ratios.19 Left ventricular subendocar
dial necrosis may account for 50 to 90%
of postoperative deaths, especially in pa
tients with coronary artery disease, left
ventricular dysfunction, hypertrophy or
aortic stenosis with high valvular gradi
ents.20 In the presence of normal coronary
arteries, subendocardial flow potential is
reflected in the supply/demand equation,
D P T I/T T I.12 An analysis of this present
series indicates that this ratio may be of
value in evaluating patients with coronary
artery disease when considered in conjunc
tion with left ventricular EF (Fig. 2). Com
parative hemodynamic evaluations for both
EF and D P T I/T T I in patients requiring
balloon support before or after ACB are
noted in Table VI.
Low mean pressure during cardiopul
monary bypass, ventricular fibrillation elec
trically induced and maintained, severe
muscle hypertrophy, prolonged anoxic ar
rest and, of course, preoperative evidence
of subendocardial ischemia may all contri-

TABLE V.—D etails of P atients in G roup 4
P a t ie n t
no.
A g e, sex

39
40
41

57, M
52, M
52, M

L V F , grade
I-IV

IV
IV
IV

EF,
%

40
34
30

C l,
l/m in -m m

0.55
2.66
3.21

Vol. 19

(P reoperative

IAPBA)

C o r o n a r y score
LVEDP,
Hg D P T I/T T I

2 mm

42
26
8

0.49
0.29
0.35

P reop.

7
2
6

P o s to p .

O p e r a tio n

A tr io v e n tr ic u la r
g ra d ie n t, m m H g

R e s u lts

7

AVR
AVR
AVR, 2ACB

100
52
70

Alive
Alive
Died

2
0

r

January 1976

75

THE CANADIAN JOURNAL OF SURGERY

TABLE VI.—Comparative H emodynamic E valuation of P atients
nous Vein B ypass Operation

with

Angina U ndergoing S aphe 

IABPA use and no. of patients
Postoperative

Preoperative

Variable
Low EF ( $ 40%)...............................
Low DPTI/TTI ( $ 0.70).................
Low EF + low D P T I/T T I..............
Neither low EF nor low DPTI/TTI

bute to poor subendocardial perfusion with
ultimate myocardial necrosis.19 IABPA re
duces the TTI and augments the DPTI. As
well, left ventricular systolic unloading will
reduce diastolic pressure and volume, which
contributes to intramyocardial pressure
gradients that impair subendocardial flow
(Fig. 3). IABPA may open dormant inter
coronary collaterals,21' 22 increase flow
through stenotic coronary arteries23 and,
by converting mean extracorporeal bypass
flow to a pulsatile wave form,24 may
provide more uniform myocardial perfusion
75 5025-

0

755025-

0
Fig. 3.—Changes in coronary blood flow/left
ventricular myocardial demand ratio in patient
in cardiogenic shock from acute myocardial in
farction. Note improvement in ratio after in
stitution of IABPA. Upper panel illustrates tracing
when patient off IABPA, DPTI/TTI = 0.67;
lower panel illustrates tracing when IABPA was
in effect, DPTI/TTI = 1.95. Hatched area =
TTI; stippled area = DPTI.

Preinfarction
angina
(M = 10)

Crescendo
angina
(n = 9)

Stable angina
(n = 11)

4
6
0
0

8
3
2
0

2
7
2
4

or protection of areas not revascularized by
saphenous vein grafting.
Use of the intra-aortic balloon pump has
been relatively free of complications and
well tolerated by patients in whom the post
operative course has been smooth. Tech
nical management by intensive care nurses
and a supervisory technician has not been
a problem and thus it is reasonable to ad
vocate wider application and general use
of this device. In our experience, the phy
siologic benefits of IABPA have allowed us
to increase the survival of patients with
severe coronary artery insufficiency under
going operation and increase the operability
of certain high-risk patients with evidence
of severe left ventricular dysfunction and
poor subendocardial perfusion.
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when shock
threatens
the lung

Abstract visualization of lung tissue

soiu-Medroi

• preserves
lysosome and
cell membranes,
thereby preventing
the release of destruc
tive lysosomal enzymes3
• preserves platelets
thereby reducing the risk
of intravascular coagulation1
• preserves leukocyte in
tegrity thereby helping to main
tain the pulmonary architecture1

helps reduce
pulmonary
damage
and increase
survival rates

The recovery of patients in shock
is often complicated by a pattern of
deteriorating pulmonary function.
This pulmonary insufficiency pro
gresses despite restoration of haemo
dynamic balance and apparent stabili
zation of the acute episode.
Under conditions of prolonged shock,
lack of oxygen at the cellular level
causes alterations in the oxygen-carbon
dioxide exchange mechanism. These
changes in cell metabolism lead ultimately
to interstitial cedema and perivascular
haemorrhage.1 Polymorphonuclear leuko
cytes aggregate in the pulmonary capillaries
and obstruct the pulmonary vascular bed.
As these trapped cells break down, they
release lysosomes, tiny subcellular par
ticles containing proteolytic enzymes.1
These enzymes attack their host cell and
go on to dapiage or destroy other cells.2
Prescribing information
The resulting tissue damage may not
on following page
readily repair itself even if the shock
patient survives.
When administered in conjunction
with standard therapeutic measures,
Solu-Medrol exerts a protective
P R O D U C T OF
effect on the lung and improves
References:
Upjohn
1. Wilson. J.W. (1972). Surg.,
the patient’s chance
Gynec. & Obstet.. 134: 675.
S TERO ID
2. Janoff, A. (1964). Shock, p. 93.
of survival.
RESEARCH
3. DeDuve.C. (1964). Injury.
Inflammation and Immunity, p.283.
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In the treatment
of shock and its
pulmonary
complications

solu-Medroi
soon enough,
often enough,
in pharmacologic
doses
Dosage and Administration:
In treating severe shock, there is a tendency
in current medical practice to use massive
(pharmacologic) doses of corticosteroids. (The
anti-inflam m atory activity of 1 mg of SoluMedrol is equal to 4 mg or more of hydrocor
tisone.)
The suggested dosage of Solu-Medrol for se
vere shock is 30 mg/kg stat and repeated in
four hours, if necessary.
Therapy is initiated by administering SoluMedrol intravenously over a period of at least
ten minutes. In general, therapy should be con
tinued only until the patient’s condition has
stabilized-usually not beyond 48 to 72 hours.
Solu-Medrol may be given by intravenous in
jection, by intravenous infusion, or by intra
muscular injection. The preferred method for
initial emergency use is intravenous injection.
Cautions: The general precautions and con
traindications to systemic corticosteroid ther
apy should apply to the use of Solu-Medrol.
However, when used for medical emergencies,
or in shock-like states, the possible lifesaving
effects must be weighed against the possible
undesired hormonal effects. In the treatment
of shock, Solu-Medrol should be adjunctive to
conventional supportive therapy such as fluid
replacement, etc. Although adverse effects
associated with high-dose short-term corticoid therapy are uncommon, peptic ulceration
may occur.
Supplied: In Mix-O-Vials containing Medrol
(as methylprednisolone sodium succinate), 40
mg, 125 mg, 500 mg, and 1 g vials with water
for injection.
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